HHS|HHS|NNP Public|Public|NNP Author|author|NN manuscript|manuscript|NN Access|Access|NNP Cancer|Cancer|NNP Gene|Gene|NNP Ther|Ther|NNP .|.|. 
Author|author|NN manuscript|manuscript|NN ;|;|: available|available|JJ in|in|IN PMC|PMC|NNP 2010|2010|CD August|August|NNP 01|01|NN .|.|. 
Published|publish|VBN in|in|IN final|final|JJ edited|edit|VBN form|form|NN as|as|IN :|:|: Cancer|Cancer|NNP Gene|Gene|NNP Ther|Ther|NNP .|.|. 
2010|2010|CD February|February|NNP ;|;|: 17|17|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 97|97|CD --|--|: 108|108|CD .|.|. 
doi|doi|FW :|:|: 10.1038|10.1038|CD /|/|SYM cgt|cgt|NN .2009.58|.2009.58|CD .|.|. 
An|a|DT Enteric|enteric|JJ Pathogen|Pathogen|NNP Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NN Typhimurium|typhimurium|NN or|or|CC Growth|growth|NN by|by|IN CD44high|cd44high|NN and|and|CC Suppresses|suppress|VBZ Tum|Tum|NNP Down|Down|NNP Regulating|regulate|VBG CD4|cd4|NN T|t|NN Mice|mouse|NNS :|:|: Critical|critical|JJ Role|role|NN of|of|IN Regulatory|Regulatory|NNP (|(|-LRB- Treg|Treg|NNP )|)|-RRB- Cell|cell|NN Expression|expression|NN in|in|IN Lipopolysaccharide|lipopolysaccharide|NN and|and|CC B|b|NN raun|raun|NN Lipoprotein|lipoprotein|NN in|in|IN Modulating|modulate|VBG Tumor|Tumor|NNP Growth|Growth|NNP Tie|Tie|NNP Liu|Liu|NNP and|and|CC Ashok|Ashok|NNP K|K|NNP Chopra|Chopra|NNP *|*|NFP Department|Department|NNP of|of|IN Microbiology|Microbiology|NNP and|and|CC Immunology|Immunology|NNP ,|,|, Institute|Institute|NNP of|of|IN Human|Human|NNP Infection|infection|NN and|and|CC Immunity|immunity|NN ,|,|, Center|Center|NNP for|for|IN Biodefense|Biodefense|NNP &|&|CC Emerging|Emerging|NNP Infectious|Infectious|NNP Diseases|Diseases|NNPS and|and|CC Sealy|Sealy|NNP Center|Center|NNP for|for|IN Vaccine|Vaccine|NNP Development|Development|NNP ,|,|, University|University|NNP of|of|IN Texas|Texas|NNP Medical|Medical|NNP Branch|Branch|NNP ,|,|, Galveston|Galveston|NNP ,|,|, TX|TX|NNP 77555|77555|CD -|-|HYPH 1070|1070|CD ,|,|, USA|USA|NNP Abstract|Abstract|NNP An|An|NNP anti-tumor|anti-tumor|JJ activity|activity|NN associated|associate|VBN with|with|IN several|several|JJ bacterial|bacterial|JJ pathogens|pathogen|NNS ,|,|, including|include|VBG Salmonella|salmonella|NN enterica|enterica|NN serovar|serovar|NN Typhimurium|typhimurium|NN ,|,|, has|have|VBZ been|be|VBN reported|report|VBN ;|;|: however|however|RB ,|,|, the|the|DT underlying|underlie|VBG immunological|immunological|JJ mechanism|mechanism|NN (|(|-LRB- s|s|AFX )|)|-RRB- that|that|WDT leads|lead|VBZ to|to|IN an|a|DT anti-tumor|anti-tumor|JJ effect|effect|NN is|be|VBZ currently|currently|RB unclear|unclear|JJ .|.|. 
Further|further|RB ,|,|, such|such|JJ pathogens|pathogen|NNS can|can|MD not|not|RB be|be|VB used|use|VBN to|to|TO suppress|suppress|VB tumor|tumor|NN growth|growth|NN because|because|IN of|of|IN their|they|PRP$ potential|potential|NN for|for|IN causing|cause|VBG sepsis|sepsis|NN .|.|. 
Recently|recently|RB ,|,|, we|we|PRP reported|report|VBD the|the|DT characterization|characterization|NN of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP isogenic|isogenic|JJ mutants|mutant|NNS from|from|IN which|which|WDT the|the|DT Braun|Braun|NNP lipoprotein|lipoprotein|NN genes|gene|NNS (|(|-LRB- lppA|lppa|NN and|and|CC B|b|NN )|)|-RRB- and|and|CC the|the|DT multicopy|multicopy|JJ repressor|repressor|NN of|of|IN high|high|JJ temperature|temperature|NN requirement|requirement|NN (|(|-LRB- msbB|msbb|NN )|)|-RRB- gene|gene|NN were|be|VBD deleted|delete|VBN .|.|. 
In|in|IN a|a|DT mouse|mouse|NN infection|infection|NN model|model|NN ,|,|, two|two|CD mutants|mutant|NNS ,|,|, namely|namely|RB ,|,|, lppB|lppb|NN /|/|HYPH msbB|msbb|NN and|and|CC lppAB|lppab|NN /|/|HYPH msbB|msbb|NN ,|,|, minimally|minimally|RB induced|induce|VBN proinflammatory|proinflammatory|JJ cytokine|cytokine|NN production|production|NN at|at|IN high|high|JJ doses|dose|NNS and|and|CC were|be|VBD non-lethal|non-lethal|JJ to|to|IN animals|animal|NNS .|.|. 
We|we|PRP demonstrated|demonstrate|VBD that|that|IN immunization|immunization|NN of|of|IN mice|mouse|NNS with|with|IN these|these|DT mutants|mutant|NNS ,|,|, followed|follow|VBN by|by|IN challenge|challenge|NN with|with|IN the|the|DT wild|wild|JJ -|-|HYPH type|type|NN S.|S.|NNP Typhimurium|Typhimurium|NNP could|could|MD significantly|significantly|RB suppress|suppress|VB tumor|tumor|NN growth|growth|NN ,|,|, as|as|IN evidenced|evidence|VBN by|by|IN an|a|DT 88|88|CD %|%|NN regression|regression|NN in|in|IN tumor|tumor|NN size|size|NN in|in|IN lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN -|-|HYPH immunized|immunize|VBN animals|animal|NNS over|over|IN a|a|DT 24|24|CD -|-|HYPH day|day|NN period|period|NN .|.|. 
However|however|RB ,|,|, the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN alone|alone|JJ was|be|VBD not|not|RB effective|effective|JJ in|in|IN modulating|modulate|VBG tumor|tumor|NN growth|growth|NN in|in|IN mice|mouse|NNS ,|,|, while|while|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN alone|alone|RB caused|cause|VBD marginal|marginal|JJ regression|regression|NN in|in|IN tumor|tumor|NN size|size|NN .|.|. 
Importantly|importantly|RB ,|,|, we|we|PRP demonstrated|demonstrate|VBD that|that|IN CD44|cd44|NN +|+|SYM cells|cell|NNS grew|grow|VBD much|much|JJ faster|faster|JJR than|than|IN CD44|cd44|NN −|−|SYM cells|cell|NNS from|from|IN human|human|JJ liver|liver|NN tumors|tumor|NNS in|in|IN mice|mouse|NNS ,|,|, leading|lead|VBG us|we|PRP to|to|TO examine|examine|VB the|the|DT possibility|possibility|NN that|that|IN S.|S.|NNP Typhimurium|Typhimurium|NNP might|might|MD down|down|RB -|-|HYPH regulate|regulate|VB CD44|cd44|NN in|in|IN tumors|tumor|NNS and|and|CC splenocytes|splenocyte|NNS of|of|IN mice|mouse|NNS .|.|. 
Consequently|consequently|RB ,|,|, we|we|PRP found|find|VBD in|in|IN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH infected|infect|VBN mice|mouse|NNS that|that|WDT tumor|tumor|NN size|size|NN regression|regression|NN could|could|MD indeed|indeed|RB be|be|VB related|relate|VBN to|to|IN the|the|DT down|down|JJ -|-|HYPH regulation|regulation|NN of|of|IN CD44high|cd44high|NN and|and|CC CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS .|.|. 
Importantly|importantly|RB ,|,|, the|the|DT role|role|NN of|of|IN lipopolysaccharide|lipopolysaccharide|NN and|and|CC Braun|Braun|NNP lipoprotein|lipoprotein|NN was|be|VBD critical|critical|JJ in|in|IN S.|S.|NNP Typhimurium|Typhimurium|NNP induced|induce|VBN -|-|HYPH anti-tumor|anti-tumor|JJ immune|immune|JJ responses|response|NNS .|.|. 
Taken|take|VBN together|together|RB ,|,|, we|we|PRP have|have|VBP defined|define|VBN new|new|JJ immune|immune|JJ mechanisms|mechanism|NNS leading|lead|VBG to|to|IN tumor|tumor|NN suppression|suppression|NN in|in|IN mice|mouse|NNS by|by|IN S.|S.|NNP Typhimurium|Typhimurium|NNP .|.|. 
Users|user|NNS may|may|MD view|view|VB ,|,|, print|print|VB ,|,|, copy|copy|VB ,|,|, and|and|CC download|download|VB text|text|NN and|and|CC data|data|NN -|-|HYPH mine|mine|NN the|the|DT content|content|NN in|in|IN such|such|JJ documents|document|NNS ,|,|, for|for|IN the|the|DT purposes|purpose|NNS of|of|IN academic|academic|JJ research|research|NN ,|,|, subject|subject|JJ always|always|RB to|to|IN the|the|DT full|full|JJ Conditions|condition|NNS of|of|IN use|use|NN :|:|: http://www.nature.com/authors/editorial_policies/license.html#terms|http://www.nature.com/authors/editorial_policies/license.html#terms|ADD *|*|NFP Correspondence|correspondence|NN :|:|: A.K.|A.K.|NNP Chopra|Chopra|NNP ,|,|, Department|Department|NNP of|of|IN Microbiology|Microbiology|NNP and|and|CC Immunology|Immunology|NNP ,|,|, 301|301|CD University|University|NNP Blvd.|Blvd.|NNP ,|,|, UTMB|UTMB|NNP ,|,|, Galveston|Galveston|NNP ,|,|, TX|TX|NNP 77555|77555|CD -|-|HYPH 1070|1070|CD ,|,|, USA|USA|NNP ,|,|, Tel|Tel|NNP :|:|: +|+|SYM 1 409-747-0578|1 409-747-0578|CD ,|,|, Fax|fax|NN :|:|: +|+|SYM 1 409-747-6869|1 409-747-6869|CD ,|,|, e-mail|e-mail|NN :|:|: achopra@utmb.edu|achopra@utmb.edu|ADD .|.|. 
Corresponding|correspond|VBG Author|author|NN :|:|: Tie|Tie|NNP Liu|Liu|NNP ,|,|, Department|Department|NNP of|of|IN Microbiology|Microbiology|NNP and|and|CC Immunology|Immunology|NNP ,|,|, University|University|NNP of|of|IN Texas|Texas|NNP Medical|Medical|NNP Branch|Branch|NNP ,|,|, 301|301|CD University|University|NNP Boulevard|Boulevard|NNP ,|,|, Medical|Medical|NNP Research|Research|NNP Building|Building|NNP 3.142|3.142|CD ,|,|, Galveston|Galveston|NNP ,|,|, TX|TX|NNP 77555|77555|CD -|-|HYPH 1070|1070|CD ;|;|: Fax|fax|NN :|:|: (409) 747-6869|(409) 747-6869|NN ;|;|: e-mail|e-mail|NN :|:|: tieliu@utmb.edu|tieliu@utmb.edu|ADD .|.|. 
Disclosures|disclosure|NNS The|the|DT authors|author|NNS have|have|VBP no|no|DT financial|financial|JJ conflict|conflict|NN of|of|IN interest|interest|NN .|.|. 
Salmonella|salmonella|NN Typhimurium|typhimurium|NN and|and|CC its|its|PRP$ mutants|mutant|NNS ;|;|: CD44|cd44|NN ;|;|: T|t|NN regulatory|regulatory|JJ (|(|-LRB- Treg|Treg|NNP )|)|-RRB- cells|cell|NNS ;|;|: tumor|tumor|NN ;|;|: mouse|mouse|NN model|model|NN Introduction|introduction|NN Salmonella|salmonella|NN enterica|enterica|NN serovar|serovar|NN Typhimurium|typhimurium|NN has|have|VBZ been|be|VBN shown|show|VBN to|to|TO possess|possess|VB anti-tumor|anti-tumor|JJ activity|activity|NN in|in|IN a|a|DT mouse|mouse|NN model|model|NN ,|,|, the|the|DT capability|capability|NN to|to|TO selectively|selectively|RB amplify|amplify|VB within|within|IN tumors|tumor|NNS ,|,|, and|and|CC express|express|VB therapeutic|therapeutic|JJ proteins|proteins|NN 1|1|CD ,|,|, 2|2|CD .|.|. 
Reports|report|NNS have|have|VBP indicated|indicate|VBN that|that|IN S.|S.|NNP Typhimurium|Typhimurium|NNP selectively|selectively|RB infects|infect|VBZ and|and|CC preferentially|preferentially|RB colonizes|colonize|VBZ solid|solid|JJ tumors|tumor|NNS of|of|IN cancer|cancer|NN patients|patient|NNS 3|3|CD --|--|: 5|5|CD ,|,|, making|make|VBG it|it|PRP potentially|potentially|RB useful|useful|JJ as|as|IN a|a|DT vehicle|vehicle|NN to|to|TO target|target|VB human|human|JJ tumors|tumor|NNS in|in|FW vivo|vivo|FW 1|1|CD ,|,|, 2|2|CD ,|,|, 6|6|CD --|--|: 8|8|CD .|.|. 
Further|further|RB ,|,|, S.|S.|NNP Typhimurium|Typhimurium|NNP has|have|VBZ a|a|DT significant|significant|JJ ability|ability|NN to|to|TO infect|infect|VB non-phagocytic|non-phagocytic|JJ cells|cell|NNS via|via|IN expression|expression|NN of|of|IN a|a|DT type|type|NN -|-|HYPH III|iii|CD secretion|secretion|NN system|system|NN (|(|-LRB- T3SS|t3ss|NN )|)|-RRB- ,|,|, which|which|WDT facilitates|facilitate|VBZ bacterial|bacterial|JJ penetration|penetration|NN of|of|IN host|host|NN cells|cell|NNS 9|9|CD .|.|. 
S.|S.|NNP Typhimurium|Typhimurium|NNP releases|release|VBZ lipopolysaccharide|lipopolysaccharide|NN (|(|-LRB- LPS|lps|NN )|)|-RRB- during|during|IN both|both|CC in|in|FW vitro|vitro|FW and|and|CC in|in|FW vivo|vivo|FW growth|growth|NN 10|10|CD ,|,|, and|and|CC its|its|PRP$ release|release|NN is|be|VBZ significantly|significantly|RB enhanced|enhance|VBN during|during|IN bacterial|bacterial|JJ lysis|lysis|NN following|follow|VBG exposure|exposure|NN to|to|IN antibiotics|antibiotic|NNS or|or|CC human|human|JJ serum|serum|NN .|.|. 
This|this|DT enhanced|enhance|VBN LPS|lps|NN release|release|NN causes|cause|VBZ septic|septic|NN shock|shock|NN 11|11|CD .|.|. 
Likewise|likewise|RB ,|,|, Braun|Braun|NNP lipoprotein|lipoprotein|NN (|(|-LRB- Lpp|lpp|NN )|)|-RRB- is|be|VBZ also|also|RB a|a|DT critical|critical|JJ bacterial|bacterial|JJ component|component|NN in|in|IN the|the|DT induction|induction|NN and|and|CC pathogenesis|pathogenesis|NN of|of|IN septic|septic|NN shock|shock|NN .|.|. 
Like|like|IN LPS|lps|NN ,|,|, it|it|PRP induces|induce|VBZ production|production|NN of|of|IN tumor|tumor|NN necrosis|necrosis|NN factor|factor|NN (|(|-LRB- TNF|tnf|NN )|)|-RRB- -|-|HYPH α|α|NN and|and|CC interleukin|interleukin|NN (|(|-LRB- IL|il|NN )|)|-RRB- -6|-6|NN in|in|IN mouse|mouse|NN and|and|CC human|human|JJ macrophages|macrophage|NNS ex|ex|FW vivo|vivo|FW 12|12|CD ,|,|, 13|13|CD ,|,|, and|and|CC leads|lead|VBZ to|to|IN lethal|lethal|JJ shock|shock|NN as|as|IN a|a|DT result|result|NN of|of|IN these|these|DT cytokine|cytokine|NN production|production|NN in|in|IN both|both|CC LPS|lps|NN -|-|HYPH responsive|responsive|JJ and|and|CC nonresponsive|nonresponsive|JJ mice|mouse|NNS 14|14|CD .|.|. 
More|more|RBR importantly|importantly|RB ,|,|, Lpp|lpp|NN synergizes|synergize|NNS with|with|IN LPS|lps|NN to|to|TO induce|induce|VB production|production|NN of|of|IN pro-inflammatory|pro-inflammatory|JJ cytokines|cytokine|NNS in|in|IN mice|mouse|NNS ,|,|, because|because|IN Lpp|lpp|NN binds|bind|VBZ to|to|IN toll|toll|NN -|-|HYPH like|like|JJ receptor|receptor|NN (|(|-LRB- TLR|tlr|NN )|)|-RRB- -2|-2|NN ,|,|, whereas|whereas|IN LPS|lps|NN binds|bind|VBZ to|to|IN TLR|tlr|NN -|-|HYPH 4|4|CD and|and|CC CD14|cd14|NN to|to|TO activate|activate|VB host|host|NN cells|cell|NNS 15|15|CD .|.|. 
The|the|DT biological|biological|JJ potency|potency|NN of|of|IN LPS|lps|NN can|can|MD be|be|VB significantly|significantly|RB reduced|reduce|VBN when|when|WRB the|the|DT multicopy|multicopy|JJ repressor|repressor|NN of|of|IN a|a|DT high|high|JJ temperature|temperature|NN requirement|requirement|NN (|(|-LRB- msbB|msbb|NN )|)|-RRB- gene|gene|NN is|be|VBZ deleted|delete|VBN from|from|IN S.|S.|NNP Typhimurium|Typhimurium|NNP 2|2|CD .|.|. 
This|this|DT gene|gene|NN codes|code|NNS for|for|IN an|a|DT enzyme|enzyme|NN which|which|WDT is|be|VBZ responsible|responsible|JJ of|of|IN adding|add|VBG myristic|myristic|JJ acid|acid|NN to|to|IN the|the|DT lipid|lipid|NN A|a|DT moiety|moiety|NN of|of|IN LPS|lps|NN 16|16|CD .|.|. 
Consequently|consequently|RB ,|,|, in|in|IN our|we|PRP$ recent|recent|JJ studies|study|NNS ,|,|, we|we|PRP characterized|characterize|VBD isogenic|isogenic|JJ mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP that|that|WDT were|be|VBD deleted|delete|VBN for|for|IN the|the|DT Braun|Braun|NNP lipoprotein|lipoprotein|NN (|(|-LRB- lppA|lppa|NN and|and|CC B|b|NN )|)|-RRB- genes|gene|NNS in|in|IN conjunction|conjunction|NN with|with|IN the|the|DT msbB|msbb|NN gene|gene|NN 16|16|CD .|.|. 
We|we|PRP provided|provide|VBD evidence|evidence|NN that|that|IN such|such|JJ mutants|mutant|NNS were|be|VBD highly|highly|RB attenuated|attenuate|VBN in|in|IN a|a|DT mouse|mouse|NN model|model|NN of|of|IN salmonellosis|salmonellosis|NN and|and|CC produced|produce|VBD minimal|minimal|JJ levels|level|NNS of|of|IN pro-inflammatory|pro-inflammatory|JJ cytokines|cytokine|NNS and|and|CC chemokines|chemokine|NNS 17|17|CD .|.|. 
We|we|PRP predicted|predict|VBD that|that|IN the|the|DT lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP would|would|MD be|be|VB excellent|excellent|JJ live|live|RB -|-|HYPH attenuated|attenuate|VBN vaccine|vaccine|NN candidates|candidate|NNS .|.|. 
Indeed|indeed|RB ,|,|, mice|mouse|NNS immunized|immunize|VBN with|with|IN such|such|JJ mutants|mutant|NNS were|be|VBD solidly|solidly|RB protected|protect|VBN against|against|IN challenge|challenge|NN with|with|IN lethal|lethal|JJ doses|dose|NNS of|of|IN wild|wild|JJ -|-|HYPH type|type|NN (|(|-LRB- WT|wt|NN )|)|-RRB- S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, in|in|IN that|that|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN and|and|CC lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS provided|provide|VBN maximum|maximum|JJ protection|protection|NN .|.|. 
These|these|DT two|two|CD mutants|mutant|NNS were|be|VBD further|further|RB characterized|characterize|VBN in|in|IN terms|term|NNS of|of|IN their|they|PRP$ immune|immune|JJ responses|response|NNS in|in|IN a|a|DT mouse|mouse|NN model|model|NN 17|17|CD and|and|CC examined|examine|VBN in|in|IN this|this|DT study|study|NN for|for|IN their|they|PRP$ anti-tumor|anti-tumor|JJ activity|activity|NN .|.|. 
CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM T|t|NN regulatory|regulatory|JJ (|(|-LRB- Treg|Treg|NNP )|)|-RRB- cells|cell|NNS have|have|VBP been|be|VBN shown|show|VBN to|to|TO be|be|VB controlling|control|VBG self|self|NN -|-|HYPH reactive|reactive|JJ T|t|NN cells|cell|NNS by|by|IN helping|help|VBG to|to|TO maintain|maintain|VB immunological|immunological|JJ self|self|NN -|-|HYPH tolerance|tolerance|NN 18|18|CD ,|,|, 19|19|CD and|and|CC hence|hence|RB are|be|VBP a|a|DT major|major|JJ obstacle|obstacle|NN in|in|IN effective|effective|JJ anti-tumor|anti-tumor|JJ immunotherapy|immunotherapy|NN 20|20|CD ,|,|, 21|21|CD .|.|. 
CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS have|have|VBP been|be|VBN reported|report|VBN to|to|TO be|be|VB specifically|specifically|RB recruited|recruit|VBN to|to|IN tumor|tumor|NN sites|site|NNS and|and|CC to|to|TO effectively|effectively|RB block|block|VB anti-tumor|anti-tumor|JJ cytotoxic|cytotoxic|JJ Tlymphocyte|tlymphocyte|NN (|(|-LRB- CTL|ctl|NN )|)|-RRB- responses|response|NNS .|.|. 
Hence|hence|RB ,|,|, the|the|DT targeted|target|VBN removal|removal|NN or|or|CC inactivation|inactivation|NN of|of|IN the|the|DT CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS in|in|IN animal|animal|NN models|model|NNS could|could|MD lead|lead|VB to|to|IN improved|improve|VBN tumor|tumor|NN immunosurveillance|immunosurveillance|NN ,|,|, better|better|JJR vaccine|vaccine|NN efficacy|efficacy|NN ,|,|, and|and|CC enhanced|enhance|VBN anti-tumor|anti-tumor|JJ immunity|immunity|NN 22|22|CD --|--|: 24|24|CD .|.|. 
Further|further|RB ,|,|, Keywords|keyword|NNS CD44|cd44|NN is|be|VBZ the|the|DT principal|principal|JJ receptor|receptor|NN of|of|IN the|the|DT hyaladherin|hyaladherin|NN receptor|receptor|NN family|family|NN ,|,|, and|and|CC CD44|cd44|NN -|-|HYPH hyaluronan|hyaluronan|NN interactions|interaction|NNS mediate|mediate|VBP cell|cell|NN adhesion|adhesion|NN and|and|CC migration|migration|NN in|in|IN various|various|JJ physiological|physiological|JJ and|and|CC pathophysiological|pathophysiological|JJ processes|process|NNS 25|25|CD --|--|: 28|28|CD .|.|. 
CD44|cd44|NN is|be|VBZ expressed|express|VBN on|on|IN many|many|JJ tissues|tissue|NNS in|in|IN developing|develop|VBG and|and|CC adult|adult|JJ humans|human|NNS ,|,|, and|and|CC it|it|PRP was|be|VBD described|describe|VBN originally|originally|RB as|as|IN a|a|DT homing|homing|NN receptor|receptor|NN required|require|VBN for|for|IN binding|binding|NN of|of|IN lymphocytes|lymphocyte|NNS to|to|IN high|high|JJ endothelial|endothelial|JJ venules|venule|NNS 29|29|CD ,|,|, 30|30|CD .|.|. 
CD44|cd44|NN has|have|VBZ also|also|RB been|be|VBN shown|show|VBN to|to|TO be|be|VB involved|involve|VBN in|in|IN lymphocyte|lymphocyte|NN activation|activation|NN in|in|IN humans|human|NNS 31|31|CD ,|,|, 32and|32and|CD in|in|IN a|a|DT mouse|mouse|NN model|model|NN 33|33|CD .|.|. 
CD44|cd44|NN expression|expression|NN by|by|IN tumor|tumor|NN cells|cell|NNS can|can|MD increase|increase|VB their|they|PRP$ interaction|interaction|NN with|with|IN endothelial|endothelial|JJ cells|cell|NNS and|and|CC transmigration|transmigration|NN across|across|IN an|a|DT endothelial|endothelial|JJ monolayer|monolayer|NN .|.|. 
Several|several|JJ reports|report|NNS have|have|VBP shown|show|VBN that|that|IN CD44|cd44|NN inhibitors|inhibitor|NNS ,|,|, including|include|VBG anti-CD44|anti-cd44|JJ monoclonal|monoclonal|JJ antibody|antibody|NN and|and|CC hyaladherin|hyaladherin|NN inhibitors|inhibitor|NNS ,|,|, can|can|MD be|be|VB used|use|VBN to|to|TO block|block|VB tumor|tumor|NN cell|cell|NN growth|growth|NN ,|,|, invasion|invasion|NN ,|,|, and|and|CC metastasis|metastasis|NN 34|34|CD ,|,|, 35|35|CD .|.|. 
In|in|IN this|this|DT study|study|NN ,|,|, we|we|PRP showed|show|VBD that|that|IN lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS alone|alone|JJ were|be|VBD not|not|RB effective|effective|JJ in|in|IN suppressing|suppress|VBG tumor|tumor|NN growth|growth|NN in|in|IN mice|mouse|NNS .|.|. 
However|however|RB ,|,|, we|we|PRP observed|observe|VBD a|a|DT significant|significant|JJ regression|regression|NN in|in|IN the|the|DT size|size|NN of|of|IN tumors|tumor|NNS implanted|implant|VBN in|in|IN mice|mouse|NNS first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC then|then|RB challenged|challenge|VBN with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP .|.|. 
Further|further|RB ,|,|, we|we|PRP noted|note|VBD a|a|DT decrease|decrease|NN in|in|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cell|cell|NN numbers|number|NNS and|and|CC down|down|RB -|-|HYPH expression|expression|NN of|of|IN CD44high|cd44high|NN in|in|IN the|the|DT spleen|spleen|NN of|of|IN mice|mouse|NNS infected|infect|VBN with|with|IN S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, which|which|WDT for|for|IN the|the|DT most|most|JJS part|part|NN could|could|MD be|be|VB mediated|mediate|VBN through|through|IN LPS|lps|NN and|and|CC Lpp|lpp|NN .|.|. 
Materials|material|NNS and|and|CC Methods|method|NNS Bacterial|bacterial|JJ cultures|culture|NNS The|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP 14028|14028|CD strain|strain|NN and|and|CC its|its|PRP$ various|various|JJ mutants|mutant|NNS used|use|VBN in|in|IN this|this|DT study|study|NN are|be|VBP listed|list|VBN in|in|IN Table|table|NN 1|1|CD .|.|. 
The|the|DT organisms|organism|NNS were|be|VBD grown|grow|VBN in|in|IN Luria|Luria|NNP -|-|HYPH Bertani|Bertani|NNP (|(|-LRB- LB|LB|NNP )|)|-RRB- broth|broth|NN or|or|CC on|on|IN LB|LB|NNP agar|agar|NN plates|plate|NNS in|in|IN the|the|DT presence|presence|NN of|of|IN the|the|DT appropriate|appropriate|JJ antibiotics|antibiotic|NNS .|.|. 
For|for|IN the|the|DT growth|growth|NN of|of|IN msbB|msbb|NN mutants|mutant|NNS ,|,|, we|we|PRP used|use|VBD a|a|DT special|special|JJ MsbB|msbb|NN medium|medium|NN as|as|IN previously|previously|RB described|describe|VBN 17|17|CD .|.|. 
The|the|DT MsbB|msbb|NN medium|medium|NN /|/|HYPH liter|liter|NN consisted|consist|VBD of|of|IN the|the|DT following|follow|VBG :|:|: 10|10|CD g|g|NN tryptone|tryptone|NN ,|,|, 5|5|CD g|g|NN Yeast|yeast|NN Extract|extract|NN ,|,|, 1|1|CD ml|ml|NN 1|1|CD M|m|NN MgSO4|mgso4|NN ,|,|, and|and|CC 1|1|CD ml|ml|NN 1|1|CD M|m|NN CaCl2|cacl2|NN .|.|. 
The|the|DT bacteria|bacterium|NNS were|be|VBD cultivated|cultivate|VBN at|at|IN 37|37|CD °C|°c|NN overnight|overnight|RB with|with|IN shaking|shake|VBG at|at|IN 200|200|CD rpm|rpm|NN ,|,|, harvested|harvest|VBN by|by|IN centrifugation|centrifugation|NN (|(|-LRB- 6,000|6,000|CD rpm|rpm|NN for|for|IN 5|5|CD min|min|NN )|)|-RRB- ,|,|, washed|wash|VBN with|with|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- ,|,|, and|and|CC resuspended|resuspend|VBN in|in|IN a|a|DT minimal|minimal|JJ amount|amount|NN of|of|IN PBS|pbs|NN .|.|. 
Bacteria|bacterium|NNS were|be|VBD counted|count|VBN by|by|IN determining|determine|VBG colonyforming|colonyform|VBG units|unit|NNS (|(|-LRB- cfu|cfu|NN )|)|-RRB- in|in|IN triplicate|triplicate|NN ,|,|, and|and|CC expressed|express|VBN as|as|IN cfu|cfu|NN /|/|SYM ml|ml|NN .|.|. 
We|we|PRP used|use|VBD 6|6|CD -|-|HYPH to|to|IN 8|8|CD -|-|HYPH week|week|NN -|-|HYPH old|old|JJ C57BL|c57bl|NN /|/|HYPH 6|6|CD ,|,|, BALB|balb|NN /|/|HYPH c|c|NN ,|,|, and|and|CC /|/|HYPH or|or|CC Swiss|swiss|JJ -|-|HYPH Webster|Webster|NNP female|female|JJ mice|mouse|NNS (|(|-LRB- Taconic|Taconic|NNP Farms|Farms|NNPS ,|,|, Germantown|Germantown|NNP ,|,|, NY|NY|NNP )|)|-RRB- .|.|. 
For|for|IN selected|select|VBN studies|study|NNS ,|,|, we|we|PRP used|use|VBD breeding|breed|VBG pairs|pair|NNS of|of|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM mice|mouse|NNS in|in|IN a|a|DT C57BL|c57bl|NN /|/|HYPH 6|6|CD background|background|NN (|(|-LRB- The|the|DT Jackson|Jackson|NNP Laboratory|Laboratory|NNP ,|,|, Bar|Bar|NNP Harbor|Harbor|NNP ,|,|, ME|ME|NNP )|)|-RRB- ,|,|, and|and|CC IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS (|(|-LRB- 2|2|CD years|year|NNS old|old|JJ )|)|-RRB- .|.|. 
We|we|PRP used|use|VBD IL|il|NN -|-|HYPH 10|10|CD +|+|SYM /|/|HYPH +|+|SYM and|and|CC IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM mice|mouse|NNS as|as|IN IL|il|NN -|-|HYPH 10|10|CD is|be|VBZ a|a|DT pleiotropic|pleiotropic|JJ cytokine|cytokine|NN with|with|IN anti-inflammatory|anti-inflammatory|JJ and|and|CC anti-angiogenic|anti-angiogenic|JJ properties|property|NNS in|in|IN in|in|FW vitro|vitro|FW and|and|CC in|in|FW vivo|vivo|FW models|model|NNS 36|36|CD ,|,|, 37|37|CD .|.|. 
High|high|JJ IL|il|NN -|-|HYPH 10|10|CD levels|level|NNS result|result|VBP in|in|IN smaller|smaller|JJR tumors|tumor|NNS ,|,|, their|they|PRP$ lesser|lesser|JJR metastases|metastase|NNS and|and|CC reduced|reduce|VBN angiogenesis|angiogenesis|NN in|in|IN humans|human|NNS ,|,|, and|and|CC low|low|JJ IL|il|NN -|-|HYPH 10|10|CD production|production|NN is|be|VBZ associated|associate|VBN with|with|IN increased|increase|VBN risk|risk|NN of|of|IN prostate|prostate|NN cancer|cancer|NN 38|38|CD .|.|. 
Mice|mouse|NNS were|be|VBD kept|keep|VBN under|under|IN specific|specific|JJ pathogen|pathogen|NN -|-|HYPH free|free|JJ conditions|condition|NNS in|in|IN filter|filter|NN -|-|HYPH topped|top|VBN cages|cage|NNS with|with|IN sterile|sterile|JJ bedding|bedding|NN and|and|CC fed|fed|NN sterile|sterile|JJ food|food|NN and|and|CC water|water|NN .|.|. 
ranging|range|VBG from|from|IN 0.5|0.5|CD ×|×|SYM 102|102|CD −|−|SYM 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN /|/|SYM 100|100|CD µl|µl|NN ,|,|, and|and|CC deaths|death|NNS were|be|VBD recorded|record|VBN for|for|IN a|a|DT 30|30|CD -|-|HYPH day|day|NN period|period|NN .|.|. 
In|in|IN some|some|DT cases|case|NNS ,|,|, mice|mouse|NNS were|be|VBD initially|initially|RB immunized|immunize|VBN with|with|IN the|the|DT mutant|mutant|NN S.|S.|NNP Typhimurium|Typhimurium|NNP strains|strain|NNS and|and|CC then|then|RB rechallenged|rechallenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP strain|strain|NN (|(|-LRB- 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN )|)|-RRB- 30|30|CD days|day|NNS after|after|IN the|the|DT initial|initial|JJ immunization|immunization|NN .|.|. 
The|the|DT animal|animal|NN experiments|experiment|NNS were|be|VBD performed|perform|VBN under|under|IN the|the|DT approved|approve|VBN Institutional|Institutional|NNP Animal|Animal|NNP Care|Care|NNP and|and|CC Use|Use|NNP Committee|Committee|NNP and|and|CC death|death|NN was|be|VBD the|the|DT end|end|NN point|point|NN of|of|IN the|the|DT study|study|NN when|when|WRB animals|animal|NNS were|be|VBD infected|infect|VBN with|with|IN the|the|DT WT|wt|NN bacteria|bacterium|NNS .|.|. 
However|however|RB ,|,|, those|those|DT animals|animal|NNS that|that|WDT were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT mutant|mutant|NN S.|S.|NNP Typhimurium|Typhimurium|NNP strains|strain|NNS and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN bacterium|bacterium|NN survived|survive|VBD and|and|CC were|be|VBD humanely|humanely|RB euthanized|euthanize|VBN after|after|IN 30|30|CD days|day|NNS .|.|. 
Animals|animal|NNS munization|munization|NN of|of|IN mice|mouse|NNS /|/|SYM im|im|NN n|n|NN tio|tio|NN fec|fec|NN In|in|IN unized|unized|JJ via|via|IN the|the|DT intraperitoneal|intraperitoneal|JJ (|(|-LRB- i.p.|i.p.|RB )|)|-RRB- route|route|NN with|with|IN :|:|: WT|wt|NN S.|S.|NNP B|B|NNP /|/|HYPH msbB|msbB|NNP mutant|mutant|NN ,|,|, and|and|CC /|/|HYPH or|or|CC the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN (|(|-LRB- Table|table|NN 1|1|CD )|)|-RRB- at|at|IN doses|dose|NNS Mice|mouse|NNS were|be|VBD infected|infected|JJ /|/|HYPH imm|imm|NN Typhimurium14028|typhimurium14028|NN ,|,|, lpp|lpp|NN Bacterial|bacterial|JJ counts|count|NNS At|at|IN indicated|indicate|VBN time|time|NN intervals|interval|NNS following|follow|VBG the|the|DT infection|infection|NN /|/|HYPH immunization|immunization|NN of|of|IN mice|mouse|NNS ,|,|, spleens|spleen|NNS were|be|VBD removed|remove|VBN and|and|CC homogenized|homogenize|VBN in|in|IN PBS|pbs|NN ,|,|, and|and|CC serial|serial|JJ dilutions|dilution|NNS of|of|IN the|the|DT homogenates|homogenate|NNS were|be|VBD plated|plate|VBN on|on|IN LB|LB|NNP and|and|CC Salmonella|Salmonella|NNP -|-|HYPH Shigella|Shigella|NNP agar|agar|NN plates|plate|NNS to|to|TO determine|determine|VB bacterial|bacterial|JJ counts|count|NNS .|.|. 
The|the|DT plates|plate|NNS were|be|VBD incubated|incubate|VBN at|at|IN 37|37|CD °C|°c|NN for|for|IN 24|24|CD to|to|IN 48|48|CD h|h|NN and|and|CC colonies|colony|NNS counted|count|VBN .|.|. 
Tumor|tumor|NN cells|cell|NNS The|the|DT B16F1|b16f1|NN melanoma|melanoma|NN cell|cell|NN line|line|NN from|from|IN ATCC|atcc|NN (|(|-LRB- American|American|NNP Type|Type|NNP Culture|Culture|NNP Collection|Collection|NNP ,|,|, Manassas|Manassas|NNP ,|,|, VA|VA|NNP )|)|-RRB- was|be|VBD cultured|culture|VBN in|in|IN Dulbecco|Dulbecco|NNP 's|'s|POS Modified|modify|VBN Eagle|Eagle|NNP Medium|Medium|NNP (|(|-LRB- DMEM|dmem|NN )|)|-RRB- supplemented|supplement|VBN with|with|IN 10|10|CD %|%|NN fetal|fetal|JJ bovine|bovine|JJ serum|serum|NN (|(|-LRB- FBS|fbs|NN )|)|-RRB- ,|,|, 100|100|CD U|u|NN /|/|SYM ml|ml|NN penicillin|penicillin|NN ,|,|, 100|100|CD µg|µg|NN /|/|SYM ml|ml|NN streptomycin|streptomycin|NN ,|,|, and|and|CC 2|2|CD mM|mm|NN of|of|IN Lglutamine|lglutamine|NN before|before|IN injections|injection|NNS into|into|IN mice|mouse|NNS under|under|IN an|a|DT approved|approve|VBN animal|animal|NN protocol|protocol|NN .|.|. 
These|these|DT cells|cell|NNS were|be|VBD grown|grow|VBN for|for|IN 6|6|CD days|day|NNS at|at|IN 37|37|CD °C|°c|NN in|in|IN the|the|DT presence|presence|NN of|of|IN 5|5|CD %|%|NN CO2|co2|NN before|before|IN injections|injection|NNS .|.|. 
Human|human|JJ liver|liver|NN cancer|cancer|NN cells|cell|NNS (|(|-LRB- from|from|IN the|the|DT Sealy|Sealy|NNP Cancer|Cancer|NNP Center|Center|NNP ,|,|, University|University|NNP of|of|IN Texas|Texas|NNP Medical|Medical|NNP Branch|Branch|NNP ,|,|, Galveston|Galveston|NNP ,|,|, TX|TX|NNP )|)|-RRB- were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti|anti|AFX human|human|JJ CD44|cd44|NN PE|pe|NN antibody|antibody|NN (|(|-LRB- PE|pe|NN ,|,|, clone|clone|NN 515|515|CD )|)|-RRB- (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP ,|,|, Franklin|Franklin|NNP Lakes|Lakes|NNP ,|,|, NJ|NJ|NNP )|)|-RRB- .|.|. 
After|after|IN washing|wash|VBG with|with|IN PBS|pbs|NN ,|,|, CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM tumor|tumor|NN cells|cell|NNS were|be|VBD isolated|isolate|VBN by|by|IN using|use|VBG a|a|DT FACSAria|facsaria|NN (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP )|)|-RRB- .|.|. 
Each|each|DT cell|cell|NN clone|clone|NN population|population|NN was|be|VBD expanded|expand|VBN in|in|IN DMEM|dmem|NN supplemented|supplement|VBN with|with|IN 10|10|CD %|%|NN FBS|fbs|NN ,|,|, 100|100|CD U|u|NN /|/|SYM ml|ml|NN penicillin|penicillin|NN ,|,|, 100|100|CD µg|µg|NN /|/|SYM ml|ml|NN streptomycin|streptomycin|NN ,|,|, and|and|CC 2|2|CD mM|mm|NN of|of|IN L|l|NN -|-|HYPH glutamine|glutamine|NN in|in|IN 96|96|CD -|-|HYPH well|well|NN tissue|tissue|NN culture|culture|NN microtiter|microtiter|NN U-bottom|u-bottom|NN plates|plate|NNS .|.|. 
ell|ell|NN injections|injection|NNS r|be|VBP c|c|NN o|o|IN m|m|NN u|u|NN T|t|NN Six|six|CD -|-|HYPH to|to|IN eight|eight|CD -|-|HYPH week|week|NN -|-|HYPH old|old|JJ female|female|JJ C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS were|be|VBD subcutaneously|subcutaneously|RB (|(|-LRB- s.c.|s.c.|JJ )|)|-RRB- injected|inject|VBN with|with|IN tumor|tumor|NN cells|cell|NNS 5|5|CD ×|×|SYM 105|105|CD /|/|SYM mouse|mouse|NN /|/|SYM 100|100|CD µl|µl|NN .|.|. 
Personnel|Personnel|NNP blinded|blind|VBD to|to|IN the|the|DT study|study|NN design|design|NN measured|measure|VBN tumor|tumor|NN growth|growth|NN by|by|IN microcaliper|microcaliper|NN 3|3|CD times|time|NNS a|a|DT week|week|NN .|.|. 
Tumor|tumor|NN volume|volume|NN was|be|VBD calculated|calculate|VBN according|accord|VBG to|to|IN the|the|DT formula|formula|NN :|:|: (|(|-LRB- length|length|NN )|)|-RRB- ×|×|SYM (|(|-LRB- width|width|NN )|)|-RRB- ×|×|SYM (|(|-LRB- width|width|NN )|)|-RRB- /|/|HYPH 2|2|CD .|.|. 
etric|etric|JJ analysis|analysis|NN Flow|Flow|NNP cytom|cytom|NNP Spleen|spleen|NN cells|cell|NNS were|be|VBD obtained|obtain|VBN from|from|IN mice|mouse|NNS infected|infect|VBN with|with|IN WT|wt|NN or|or|CC mutant|mutant|NN strains|strain|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP .|.|. 
Splenocytes|Splenocytes|NNP (|(|-LRB- 105|105|CD )|)|-RRB- were|be|VBD suspended|suspend|VBN in|in|IN PBS|pbs|NN and|and|CC 1|1|CD %|%|NN FBS|fbs|NN ,|,|, and|and|CC incubated|incubate|VBN with|with|IN mouse|mouse|NN CD16|cd16|NN /|/|HYPH CD32|cd32|NN monoclonal|monoclonal|JJ antibodies|antibody|NNS (|(|-LRB- 0.25|0.25|CD µg|µg|NN /|/|SYM 100|100|CD µl|µl|NN )|)|-RRB- (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP )|)|-RRB- for|for|IN 15|15|CD min|min|NN at|at|IN room|room|NN temperature|temperature|NN .|.|. 
These|these|DT antibodies|antibody|NNS were|be|VBD added|add|VBN to|to|TO block|block|VB antibody|antibody|NN binding|binding|NN to|to|IN mouse|mouse|NN Fc|fc|NN -|-|HYPH γ|γ|SYM receptor|receptor|NN -|-|HYPH bearing|bear|VBG cells|cell|NNS .|.|. 
Then|then|RB ,|,|, the|the|DT cells|cell|NNS were|be|VBD washed|wash|VBN twice|twice|RB with|with|IN PBS|pbs|NN plus|plus|CC 1|1|CD %|%|NN FBS|fbs|NN .|.|. 
To|to|TO quantitatite|quantitatite|VB T|t|NN cells|cell|NNS ,|,|, the|the|DT cell|cell|NN suspension|suspension|NN was|be|VBD incubated|incubate|VBN for|for|IN 60|60|CD min|min|NN at|at|IN 4|4|CD °C|°c|NN with|with|IN anti-CD4|anti-cd4|NN (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP ,|,|, clone|clone|NN GK1|gk1|NN .5|.5|CD )|)|-RRB- conjugated|conjugate|VBN to|to|IN fluorescein|fluorescein|NN isothiocyanate|isothiocyanate|NN [|[|-LRB- FITC|fitc|NN ]|]|-RRB- (|(|-LRB- 0.25|0.25|CD µg|µg|NN /|/|SYM 100|100|CD µl|µl|NN )|)|-RRB- ,|,|, anti-CD44|anti-cd44|NN (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP ,|,|, clone|clone|NN IM7|im7|NN )|)|-RRB- antibody|antibody|NN conjugated|conjugate|VBN to|to|IN phycoerythrin|phycoerythrin|NN (|(|-LRB- PE|pe|NN )|)|-RRB- (|(|-LRB- 0.1|0.1|CD µg|µg|NN /|/|SYM 100|100|CD µl|µl|NN )|)|-RRB- ,|,|, and|and|CC anti-CD25|anti-cd25|NN (|(|-LRB- BD|BD|NNP Bioscience|Bioscience|NNP ,|,|, clone|clone|NN 3C7|3c7|NN )|)|-RRB- antibody|antibody|NN conjugated|conjugate|VBN to|to|IN anti|anti|AFX ¬|¬|SYM Results|result|NNS allophycocyanin|allophycocyanin|NN (|(|-LRB- APC|apc|NN )|)|-RRB- (|(|-LRB- 0.1|0.1|CD µg|µg|NN /|/|SYM 100|100|CD µl|µl|NN )|)|-RRB- .|.|. 
Subsequent|subsequent|JJ to|to|IN incubation|incubation|NN ,|,|, the|the|DT cells|cell|NNS were|be|VBD washed|wash|VBN twice|twice|RB with|with|IN PBS|pbs|NN and|and|CC then|then|RB analyzed|analyze|VBN by|by|IN FACScan|FACScan|NNP flow|flow|NN cytometry|cytometry|NN using|use|VBG CellQuest|CellQuest|NNP (|(|-LRB- Becton|Becton|NNP Dickinson|Dickinson|NNP ,|,|, Mountain|Mountain|NNP View|View|NNP ,|,|, CA|CA|NNP )|)|-RRB- software|software|NN .|.|. 
The|the|DT corresponding|correspond|VBG isotype|isotype|NN controls|control|NNS (|(|-LRB- rat|rat|NN IgG1|igg1|NN ,|,|, IgG2a|igg2a|NN ,|,|, and|and|CC IgG2b|igg2b|NN )|)|-RRB- were|be|VBD purchased|purchase|VBN from|from|IN eBioscience|ebioscience|NN (|(|-LRB- San|San|NNP Diego|Diego|NNP ,|,|, CA|CA|NNP )|)|-RRB- and|and|CC BD|BD|NNP Bioscience|Bioscience|NNP ,|,|, respectively|respectively|RB .|.|. 
Statistics|statistics|NNS At|at|IN least|least|JJS three|three|CD independent|independent|JJ experiments|experiment|NNS were|be|VBD performed|perform|VBN ,|,|, and|and|CC the|the|DT data|datum|NNS were|be|VBD analyzed|analyze|VBN using|use|VBG Student|Student|NNP 's|'s|POS t|t|NN test|test|NN .|.|. 
P|p|NN values|value|NNS of|of|IN ≤|≤|SYM 0.05|0.05|CD were|be|VBD considered|consider|VBN significant|significant|JJ .|.|. 
Statistically|statistically|RB significant|significant|JJ values|value|NNS are|be|VBP referred|refer|VBN to|to|IN as|as|IN follows|follow|VBZ :|:|: *|*|NFP ,|,|, p|p|NN <|<|SYM 0.05|0.05|CD ;|;|: **|**|NFP ,|,|, p|p|NN <|<|SYM 0.01|0.01|CD ;|;|: ***|***|NFP ,|,|, p|p|NN <|<|SYM 0.001|0.001|CD .|.|. 
T|T|NNP S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS on|on|IN tumor|tumor|NN growth|growth|NN We|we|PRP opted|opt|VBD to|to|IN immunize|immunize|NN mice|mouse|NNS with|with|IN various|various|JJ S.|S.|NNP Typhimurium|typhimurium|NN strains|strain|NNS before|before|IN transplantation|transplantation|NN of|of|IN tumors|tumor|NNS ,|,|, as|as|IN we|we|PRP did|do|VBD not|not|RB intent|intent|JJ to|to|TO develop|develop|VB tumor|tumor|NN -|-|HYPH antigen|antigen|NN -|-|HYPH specific|specific|JJ immune|immune|JJ /|/|HYPH memory|memory|NN response|response|NN ,|,|, which|which|WDT could|could|MD potentially|potentially|RB interfere|interfere|VB with|with|IN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH induced|induce|VBN strong|strong|JJ cellular|cellular|JJ and|and|CC humoral|humoral|JJ immune|immune|JJ responses|response|NNS .|.|. 
Further|further|RB ,|,|, as|as|IN discussed|discuss|VBN in|in|IN the|the|DT next|next|JJ section|section|NN ,|,|, it|it|PRP was|be|VBD important|important|JJ to|to|IN immunize|immunize|NN animals|animal|NNS with|with|IN the|the|DT mutant|mutant|NN S.|S.|NNP Typhimurium|Typhimurium|NNP strains|strain|NNS as|as|IN we|we|PRP could|could|MD use|use|VB high|high|JJ doses|dose|NNS of|of|IN them|they|PRP without|without|IN inducing|induce|VBG any|any|DT lethality|lethality|NN and|and|CC then|then|RB challenge|challenge|NN mice|mouse|NNS with|with|IN a|a|DT high|high|JJ dose|dose|NN of|of|IN WT|wt|NN bacteria|bacterium|NNS ,|,|, which|which|WDT otherwise|otherwise|RB will|will|MD be|be|VB lethal|lethal|JJ to|to|IN animals|animal|NNS in|in|IN an|a|DT un-immunized|un-immunized|JJ group|group|NN .|.|. 
Finally|finally|RB ,|,|, people|people|NNS traveling|travel|VBG from|from|IN the|the|DT developed|developed|JJ world|world|NN to|to|IN developing|develop|VBG countries|country|NNS are|be|VBP invariably|invariably|RB vaccinated|vaccinate|VBN with|with|IN the|the|DT live|live|JJ -|-|HYPH attenuated|attenuate|VBN Salmonella|salmonella|NN strain|strain|NN and|and|CC therefore|therefore|RB it|it|PRP appeared|appear|VBD logical|logical|JJ to|to|IN immunize|immunize|NN animals|animal|NNS with|with|IN S.|S.|NNP Typhimurium|Typhimurium|NNP .|.|. 
ct|ct|NN of|of|IN W|W|NNP ffe|ffe|NN E|e|NN To|to|TO delineate|delineate|VB whether|whether|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ mutant|mutant|JJ strains|strain|NNS suppressed|suppress|VBD the|the|DT growth|growth|NN of|of|IN melanomas|melanoma|NNS ,|,|, mice|mouse|NNS were|be|VBD infected|infect|VBN with|with|IN 50|50|CD cfu|cfu|NN /|/|SYM mouse|mouse|NN of|of|IN either|either|CC the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN or|or|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN strain|strain|NN .|.|. 
Mice|mouse|NNS injected|inject|VBN with|with|IN PBS|pbs|NN served|serve|VBD as|as|IN a|a|DT negative|negative|JJ control|control|NN .|.|. 
After|after|IN 30|30|CD days|day|NNS ,|,|, B16|b16|NN cells|cell|NNS (|(|-LRB- 5|5|CD ×|×|SYM 105|105|CD )|)|-RRB- were|be|VBD subcutaneously|subcutaneously|RB injected|inject|VBN into|into|IN mice|mouse|NNS .|.|. 
The|the|DT mean|mean|JJ tumor|tumor|NN size|size|NN for|for|IN various|various|JJ bacterial|bacterial|JJ strains|strain|NNS after|after|IN 24|24|CD days|day|NNS was|be|VBD :|:|: WT|wt|NN S.|S.|NNP Typhumirum|Typhumirum|NNP ,|,|, 640|640|CD +|+|SYM /|/|HYPH −|−|SYM 52|52|CD mm3|mm3|NN ;|;|: lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN ,|,|, 798|798|CD +|+|SYM /|/|HYPH −|−|SYM 65|65|CD mm3|mm3|NN ;|;|: lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN ,|,|, 871|871|CD +|+|SYM /|/|HYPH −|−|SYM 62|62|CD mm3|mm3|NN ;|;|: and|and|CC PBS|pbs|NN ,|,|, 912|912|CD +|+|SYM /|/|HYPH −|−|SYM 74|74|CD mm3|mm3|NN (|(|-LRB- Figure|figure|NN 1A|1a|NN )|)|-RRB- .|.|. 
As|as|IN can|can|MD be|be|VB noted|note|VBN from|from|IN this|this|DT figure|figure|NN ,|,|, tumor|tumor|NN size|size|NN was|be|VBD inhibited|inhibit|VBN in|in|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH infected|infect|VBN mice|mouse|NNS by|by|IN a|a|DT statistically|statistically|RB significant|significant|JJ 30|30|CD %|%|NN compared|compare|VBN to|to|IN the|the|DT rate|rate|NN in|in|IN animals|animal|NNS that|that|WDT were|be|VBD given|give|VBN PBS|pbs|NN alone|alone|RB .|.|. 
The|the|DT decreased|decrease|VBN tumor|tumor|NN size|size|NN was|be|VBD only|only|RB marginal|marginal|JJ (|(|-LRB- 12|12|CD %|%|NN )|)|-RRB- ,|,|, however|however|RB ,|,|, in|in|IN mice|mouse|NNS infected|infect|VBN with|with|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN after|after|IN 24|24|CD days|day|NNS ,|,|, and|and|CC non-existent|non-existent|JJ for|for|IN up|up|RB to|to|IN 21|21|CD days|day|NNS in|in|IN animals|animal|NNS infected|infect|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN when|when|WRB compared|compare|VBN to|to|IN the|the|DT PBS|pbs|NN controls|control|NNS .|.|. 
A|a|DT slight|slight|JJ ,|,|, but|but|CC statistically|statistically|RB insignificant|insignificant|JJ decrease|decrease|NN in|in|IN tumor|tumor|NN size|size|NN occurred|occur|VBD after|after|IN 24|24|CD days|day|NNS with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN (|(|-LRB- Figure|figure|NN 1A|1a|NN )|)|-RRB- .|.|. 
Consequently|consequently|RB ,|,|, we|we|PRP further|further|RB investigated|investigate|VBD ,|,|, using|use|VBG a|a|DT different|different|JJ approach|approach|NN ,|,|, the|the|DT anti-tumor|anti-tumor|JJ effects|effect|NNS of|of|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ mutants|mutant|NNS .|.|. 
In|in|IN this|this|DT set|set|NN of|of|IN experiments|experiment|NNS ,|,|, mice|mouse|NNS were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
Our|we|PRP$ previous|previous|JJ studies|study|NNS indicated|indicate|VBD that|that|IN mice|mouse|NNS were|be|VBD fully|fully|RB protected|protect|VBN against|against|IN mortality|mortality|NN by|by|IN i.p.|i.p.|RB doses|dose|NNS of|of|IN up|up|RB to|to|IN 1|1|CD ×|×|SYM 106|106|CD −|−|SYM 1|1|CD ×|×|SYM 107|107|CD cfu|cfu|NN of|of|IN these|these|DT mutants|mutant|NNS and|and|CC demonstrated|demonstrate|VBD that|that|IN animals|animal|NNS immunized|immunize|VBN with|with|IN the|the|DT above|above|JJ mutants|mutant|NNS at|at|IN doses|dose|NNS of|of|IN 1|1|CD ×|×|SYM 106|106|CD −|−|SYM 1|1|CD ×|×|SYM 107|107|CD cfu|cfu|NN were|be|VBD 100|100|CD %|%|NN protected|protect|VBN against|against|IN similar|similar|JJ doses|dose|NNS of|of|IN the|the|DT WT|wt|NN bacteria|bacterium|NNS after|after|IN rechallenge|rechallenge|NN 17|17|CD .|.|. 
After|after|IN 30|30|CD days|day|NNS of|of|IN immunization|immunization|NN of|of|IN these|these|DT mice|mouse|NNS with|with|IN the|the|DT above|above|JJ mutants|mutant|NNS ,|,|, we|we|PRP rechallenged|rechallenge|VBD them|they|PRP with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
Two|two|CD weeks|week|NNS after|after|IN rechallenge|rechallenge|NN of|of|IN mice|mouse|NNS with|with|IN the|the|DT WT|wt|NN bacteria|bacterium|NNS ,|,|, B16|b16|NN cells|cell|NNS (|(|-LRB- 5|5|CD ×|×|SYM 105|105|CD )|)|-RRB- were|be|VBD implanted|implant|VBN s.c.|s.c.|JJ into|into|IN the|the|DT animals|animal|NNS .|.|. 
The|the|DT mean|mean|JJ tumor|tumor|NN sizes|size|NNS in|in|IN mice|mouse|NNS immunized|immunize|VBN with|with|IN the|the|DT mutants|mutant|NNS ,|,|, followed|follow|VBN by|by|IN WT|wt|NN infection|infection|NN ,|,|, were|be|VBD as|as|IN follows|follow|VBZ :|:|: lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN alone|alone|RB ,|,|, 863|863|CD +|+|SYM /|/|HYPH −|−|SYM 71|71|CD mm3|mm3|NN ;|;|: lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN alone|alone|RB ,|,|, 660|660|CD +|+|SYM /|/|HYPH −|−|SYM 49|49|CD mm3|mm3|NN ,|,|, lppAB|lppab|NN /|/|HYPH msbB|msbb|NN +|+|SYM WT|wt|NN ,|,|, 470|470|CD +|+|SYM /|/|HYPH −|−|SYM 31|31|CD mm3|mm3|NN ,|,|, and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN +|+|SYM WT|wt|NN ,|,|, 110|110|CD +|+|SYM /|/|HYPH −|−|SYM 9|9|CD mm3|mm3|NN (|(|-LRB- Figure|figure|NN 1B|1b|NN )|)|-RRB- .|.|. 
The|the|DT tumor|tumor|NN size|size|NN in|in|IN mice|mouse|NNS injected|inject|VBN with|with|IN PBS|pbs|NN alone|alone|RB was|be|VBD 903|903|CD +|+|SYM /|/|HYPH −|−|SYM 86|86|CD mm3|mm3|NN and|and|CC served|serve|VBD as|as|IN a|a|DT positive|positive|JJ control|control|NN .|.|. 
It|it|PRP is|be|VBZ evident|evident|JJ from|from|IN these|these|DT data|datum|NNS that|that|WDT tumor|tumor|NN size|size|NN regressed|regress|VBN in|in|IN the|the|DT animals|animal|NNS first|first|RB immunized|immunize|VBN with|with|IN the|the|DT mutants|mutant|NNS and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, and|and|CC that|that|IN lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS ,|,|, respectively|respectively|RB ,|,|, provided|provide|VBN 48|48|CD %|%|NN and|and|CC 88|88|CD %|%|NN protection|protection|NN .|.|. 
The|the|DT protection|protection|NN afforded|afford|VBN by|by|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN and|and|CC lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS alone|alone|RB at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN was|be|VBD 27|27|CD %|%|NN and|and|CC 5|5|CD %|%|NN ,|,|, respectively|respectively|RB (|(|-LRB- Figure|figure|NN 1B|1b|NN )|)|-RRB- .|.|. 
To|to|TO define|define|VB the|the|DT underlying|underlying|JJ mechanism|mechanism|NN (|(|-LRB- s|s|AFX )|)|-RRB- involved|involve|VBN in|in|IN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH induced|induce|VBN tumor|tumor|NN growth|growth|NN suppression|suppression|NN ,|,|, we|we|PRP infected|infect|VBD Swiss|Swiss|NNP -|-|HYPH Webster|Webster|NNP mice|mouse|NNS with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS (|(|-LRB- 1|1|CD ×|×|SYM 103cfu|103cfu|CD /|/|SYM mouse|mouse|NN )|)|-RRB- .|.|. 
After|after|IN 5|5|CD days|day|NNS of|of|IN infection|infection|NN ,|,|, spleens|spleen|NNS from|from|IN infected|infected|JJ mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN anti-CD4|anti-cd4|JJ FITC|fitc|NN and|and|CC anti-CD25|anti-cd25|JJ APC|apc|NN ,|,|, and|and|CC the|the|DT splenocytes|splenocyte|NNS analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
We|we|PRP found|find|VBD that|that|IN the|the|DT CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS decreased|decrease|VBD significantly|significantly|RB in|in|IN the|the|DT WT|wt|NN group|group|NN of|of|IN infected|infected|JJ mice|mouse|NNS (|(|-LRB- 0.5|0.5|CD %|%|NN )|)|-RRB- compared|compare|VBN to|to|IN uninfected|uninfected|JJ animals|animal|NNS (|(|-LRB- 1.6|1.6|CD %|%|NN ,|,|, a|a|DT decrease|decrease|NN of|of|IN 69|69|CD %|%|NN )|)|-RRB- (|(|-LRB- Figure|figure|NN 2A|2a|NN )|)|-RRB- .|.|. 
The|the|DT number|number|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS decreased|decrease|VBD slightly|slightly|RB by|by|IN 31|31|CD %|%|NN in|in|IN mice|mouse|NNS infected|infect|VBN with|with|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN (|(|-LRB- 1.1|1.1|CD %|%|NN versus|versus|CC 1.6|1.6|CD %|%|NN for|for|IN control|control|NN )|)|-RRB- ,|,|, and|and|CC minimally|minimally|RB affected|affect|VBN (|(|-LRB- 1.5|1.5|CD %|%|NN )|)|-RRB- in|in|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN -|-|HYPH infected|infect|VBN mice|mouse|NNS compared|compare|VBN to|to|IN the|the|DT controls|control|NNS (|(|-LRB- 1.6|1.6|CD %|%|NN )|)|-RRB- .|.|. 
The|the|DT percentage|percentage|NN of|of|IN CD4|cd4|NN +|+|SYM cells|cell|NNS were|be|VBD slightly|slightly|RB decreased|decrease|VBN in|in|IN animals|animal|NNS infected|infect|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP (|(|-LRB- 18|18|CD %|%|NN )|)|-RRB- when|when|WRB compared|compare|VBN to|to|IN animals|animal|NNS infected|infect|VBN with|with|IN either|either|CC the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN (|(|-LRB- 21|21|CD %|%|NN )|)|-RRB- or|or|CC the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN (|(|-LRB- 22|22|CD %|%|NN )|)|-RRB- mutant|mutant|NN and|and|CC /|/|HYPH or|or|CC those|those|DT mice|mouse|NNS that|that|WDT were|be|VBD only|only|RB given|give|VBN PBS|pbs|NN (|(|-LRB- 24|24|CD %|%|NN )|)|-RRB- .|.|. 
In|in|IN addition|addition|NN we|we|PRP found|find|VBD that|that|IN the|the|DT expression|expression|NN of|of|IN gene|gene|NN -|-|HYPH encoding|encode|VBG Forkhead|forkhead|NN box|box|NN P3|p3|NN (|(|-LRB- Foxp3|foxp3|NN )|)|-RRB- ,|,|, which|which|WDT controls|control|VBZ Treg|Treg|NNP cell|cell|NN development|development|NN and|and|CC their|they|PRP$ functions|function|NNS 39|39|CD ,|,|, was|be|VBD down|down|RB -|-|HYPH regulated|regulate|VBN in|in|IN the|the|DT splenocytes|splenocyte|NNS of|of|IN mice|mouse|NNS infected|infect|VBN with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP (|(|-LRB- 0.6|0.6|CD %|%|NN )|)|-RRB- ,|,|, when|when|WRB compared|compare|VBN to|to|IN splenocytes|splenocyte|NNS of|of|IN control|control|NN uninfected|uninfected|JJ mice|mouse|NNS (|(|-LRB- 1.8|1.8|CD %|%|NN )|)|-RRB- .|.|. 
As|as|IN a|a|DT positive|positive|JJ control|control|NN ,|,|, we|we|PRP used|use|VBD splenocytes|splenocyte|NNS treated|treat|VBN with|with|IN S.|S.|NNP Typhimurium|Typhimurium|NNP lipopolysaccharide|lipopolysaccharide|NN (|(|-LRB- 3|3|CD µg|µg|NN /|/|SYM ml|ml|NN )|)|-RRB- ,|,|, which|which|WDT ,|,|, as|as|IN expected|expect|VBN ,|,|, decreased|decrease|VBD the|the|DT expression|expression|NN of|of|IN the|the|DT gene|gene|NN -|-|HYPH encoding|encode|VBG Foxp3|foxp3|NN significantly|significantly|RB (|(|-LRB- 0.31|0.31|CD %|%|NN )|)|-RRB- compared|compare|VBN to|to|IN the|the|DT controls|control|NNS (|(|-LRB- Figure|figure|NN 2B|2b|NN )|)|-RRB- .|.|. 
Some|some|DT downregulation|downregulation|NN of|of|IN T|t|NN cell|cell|NN activation|activation|NN (|(|-LRB- 20|20|CD %|%|NN )|)|-RRB- was|be|VBD also|also|RB seen|see|VBN in|in|IN splenocytes|splenocyte|NNS infected|infect|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP ex|ex|FW vivo|vivo|FW .|.|. 
ation|ation|NN of|of|IN mice|mouse|NNS with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN followed|follow|VBN by|by|IN challenge|challenge|NN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP rium|rium|NNP increased|increase|VBD the|the|DT number|number|NN of|of|IN CD4|cd4|NN ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP ,|,|, natural|natural|JJ killer|killer|NN (|(|-LRB- NK|NK|NNP )|)|-RRB- cells|cell|NNS as|as|IN acrophages|acrophage|NNS in|in|IN the|the|DT tumor|tumor|NN of|of|IN mice|mouse|NNS An|a|DT important|important|JJ question|question|NN which|which|WDT should|should|MD be|be|VB considered|consider|VBN is|be|VBZ whether|whether|IN there|there|EX are|be|VBP increases|increase|NNS in|in|IN T|t|NN -|-|HYPH and|and|CC /|/|HYPH or|or|CC NK|NK|NNP cell|cell|NN lytic|lytic|JJ activity|activity|NN against|against|IN B16|b16|NN melanoma|melanoma|NN cells|cell|NNS in|in|IN mice|mouse|NNS which|which|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT S.|S.|NNP Typhimurium|Typhimurium|NNP mutant|mutant|NN (|(|-LRB- e.g.|e.g.|FW ,|,|, lppAB|lppab|NN /|/|HYPH msbB|msbb|NN )|)|-RRB- and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP compared|compare|VBN to|to|IN those|those|DT mice|mouse|NNS that|that|WDT were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT mutant|mutant|NN but|but|CC challenged|challenge|VBN with|with|IN the|the|DT same|same|JJ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN .|.|. 
The|the|DT above|above|JJ -|-|HYPH mentioned|mention|VBN scenarios|scenario|NNS would|would|MD lead|lead|VB to|to|IN reduced|reduce|VBN tumor|tumor|NN growth|growth|NN .|.|. 
Therefore|therefore|RB ,|,|, we|we|PRP immunized|immunize|VBD C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
After|after|IN 30|30|CD days|day|NNS ,|,|, we|we|PRP challenged|challenge|VBD them|they|PRP with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP at|at|IN a|a|DT similar|similar|JJ dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
After|after|IN two|two|CD weeks|week|NNS ,|,|, B16|b16|NN cells|cell|NNS (|(|-LRB- 5|5|CD ×|×|SYM 105|105|CD )|)|-RRB- were|be|VBD implanted|implant|VBN s.c.|s.c.|JJ into|into|IN the|the|DT animals|animal|NNS ,|,|, and|and|CC three|three|CD weeks|week|NNS later|later|RB ,|,|, tumor|tumor|NN cells|cell|NNS from|from|IN these|these|DT mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN CD4|cd4|NN -|-|HYPH PE|pe|NN -|-|HYPH Cy7|cy7|NN ,|,|, CD25|cd25|NN -|-|HYPH APC|apc|NN ,|,|, NK1.1|nk1.1|NN -|-|HYPH FITC|fitc|NN ,|,|, CD11b|cd11b|NN -|-|HYPH PE|pe|NN ,|,|, CD3|cd3|NN -|-|HYPH PE|pe|NN ,|,|, interferon|interferon|NN (|(|-LRB- IFN|ifn|NN )|)|-RRB- -|-|HYPH γ|γ|SYM --|--|: FITC|fitc|NN antibody|antibody|NN and|and|CC analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
Our|we|PRP$ data|datum|NNS indicated|indicate|VBD that|that|IN the|the|DT number|number|NN of|of|IN CD4|cd4|NN ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM ,|,|, and|and|CC NK|NK|NNP cells|cell|NNS as|as|RB well|well|RB as|as|IN macrophages|macrophage|NNS were|be|VBD increased|increase|VBN to|to|IN 1.8|1.8|CD %|%|NN ,|,|, 3.2|3.2|CD %|%|NN ,|,|, 2.6|2.6|CD %|%|NN ,|,|, and|and|CC 7|7|CD %|%|NN ,|,|, respectively|respectively|RB ,|,|, in|in|IN tumors|tumor|NNS of|of|IN mice|mouse|NNS that|that|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN before|before|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP challenge|challenge|NN .|.|. 
These|these|DT numbers|number|NNS were|be|VBD in|in|IN contrast|contrast|NN to|to|IN Infection|infection|NN of|of|IN mice|mouse|NNS with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN down|down|RB -|-|HYPH regulated|regulate|VBN expression|expression|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS Immuniz|Immuniz|NNP Typhimu|Typhimu|NNP well|well|RB as|as|IN m|m|NN 0.1|0.1|CD %|%|NN ,|,|, 0.4|0.4|CD %|%|NN ,|,|, 0.5|0.5|CD %|%|NN ,|,|, and|and|CC 1.5|1.5|CD %|%|NN in|in|IN those|those|DT animals|animal|NNS that|that|WDT were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT mutant|mutant|NN and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT mutant|mutant|NN .|.|. 
Likewise|likewise|RB ,|,|, animals|animal|NNS that|that|WDT were|be|VBD given|give|VBN only|only|RB PBS|pbs|NN had|have|VBD the|the|DT following|follow|VBG percentages|percentage|NNS of|of|IN CD4|cd4|NN ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM ,|,|, NK|NK|NNP ,|,|, and|and|CC macrophages|macrophage|NNS :|:|: 0.1|0.1|CD %|%|NN ,|,|, 0.3|0.3|CD %|%|NN ,|,|, 0.2|0.2|CD %|%|NN ,|,|, and|and|CC 1.6|1.6|CD %|%|NN ,|,|, respectively|respectively|RB .|.|. 
Importantly|importantly|RB ,|,|, the|the|DT percentage|percentage|NN of|of|IN IFN|IFN|NNP -|-|HYPH γ|γ|SYM producing|produce|VBG T|t|NN cells|cell|NNS that|that|WDT infiltrated|infiltrate|VBD into|into|IN tumor|tumor|NN of|of|IN mice|mouse|NNS that|that|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP was|be|VBD also|also|RB much|much|RB higher|higher|JJR compared|compare|VBN to|to|IN in|in|IN tumors|tumor|NNS of|of|IN mice|mouse|NNS that|that|WDT were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN and|and|CC subsequently|subsequently|RB challenged|challenge|VBN with|with|IN the|the|DT mutant|mutant|NN .|.|. 
Animals|animal|NNS given|give|VBN only|only|RB the|the|DT PBS|pbs|NN but|but|CC injected|inject|VBN with|with|IN B16|b16|NN cells|cell|NNS had|have|VBD baseline|baseline|JJ level|level|NN of|of|IN IFN|IFN|NNP -|-|HYPH γ|γ|SYM (|(|-LRB- Figure|figure|NN 3A|3a|NN --|--|: C|c|NN )|)|-RRB- .|.|. 
WT|wt|NN and|and|CC lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP down|down|RB regulated|regulate|VBD the|the|DT expression|expression|NN of|of|IN CD44|cd44|NN in|in|IN mouse|mouse|NN melanoma|melanoma|NN B16|b16|NN cells|cell|NNS in|in|FW vitro|vitro|FW and|and|CC in|in|IN the|the|DT spleens|spleen|NNS of|of|IN mice|mouse|NNS in|in|FW vivo|vivo|FW We|we|PRP cultured|culture|VBD B16|b16|NN cells|cell|NNS with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS at|at|IN a|a|DT multiplicity|multiplicity|NN of|of|IN infection|infection|NN of|of|IN 1|1|CD in|in|IN DMEM|dmem|NN at|at|IN 37|37|CD °C|°c|NN in|in|IN the|the|DT presence|presence|NN of|of|IN 5|5|CD %|%|NN CO2|co2|NN .|.|. 
After|after|IN 24|24|CD h|h|NN of|of|IN incubation|incubation|NN ,|,|, the|the|DT cells|cell|NNS were|be|VBD harvested|harvest|VBN and|and|CC stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN and|and|CC analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
As|as|IN noted|note|VBN from|from|IN Figure|figure|NN 4A|4a|NN ,|,|, WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH infected|infect|VBN B16|b16|NN cells|cell|NNS exhibited|exhibit|VBD a|a|DT significant|significant|JJ decrease|decrease|NN in|in|IN the|the|DT expression|expression|NN of|of|IN CD44|cd44|NN marker|marker|NN (|(|-LRB- 69|69|CD %|%|NN )|)|-RRB- compared|compare|VBN to|to|IN that|that|DT of|of|IN control|control|NN (|(|-LRB- 83|83|CD %|%|NN )|)|-RRB- .|.|. 
Likewise|likewise|RB ,|,|, the|the|DT expression|expression|NN of|of|IN CD44|cd44|NN showed|show|VBD a|a|DT downward|downward|JJ trend|trend|NN ,|,|, with|with|IN decreases|decrease|NNS to|to|IN 74|74|CD %|%|NN and|and|CC 71|71|CD %|%|NN in|in|IN B16|b16|NN cells|cell|NNS infected|infect|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN ,|,|, respectively|respectively|RB ,|,|, compared|compare|VBN to|to|IN uninfected|uninfected|JJ B16|b16|NN cells|cell|NNS (|(|-LRB- 83|83|CD %|%|NN )|)|-RRB- .|.|. 
We|we|PRP also|also|RB infected|infect|VBD Swiss|Swiss|NNP -|-|HYPH Webster|Webster|NNP mice|mouse|NNS with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS (|(|-LRB- 1|1|CD ×|×|SYM 103|103|CD cfu|cfu|NN /|/|SYM mouse|mouse|NN )|)|-RRB- .|.|. 
After|after|IN 5|5|CD days|day|NNS of|of|IN infection|infection|NN ,|,|, spleen|spleen|NN cells|cell|NNS were|be|VBD stained|stain|VBN with|with|IN anti-CD44|anti-cd44|JJ PE|pe|NN ,|,|, and|and|CC analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
As|as|IN noted|note|VBN from|from|IN Figure|figure|NN 4B|4b|NN ,|,|, the|the|DT splenocytes|splenocyte|NNS of|of|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH infected|infect|VBN group|group|NN exhibited|exhibit|VBD a|a|DT significant|significant|JJ decrease|decrease|NN (|(|-LRB- 3.4|3.4|CD %|%|NN versus|versus|CC 12.6|12.6|CD %|%|NN ;|;|: indicated|indicate|VBN by|by|IN an|a|DT arrow|arrow|NN )|)|-RRB- in|in|IN the|the|DT expression|expression|NN of|of|IN CD44high|cd44high|NN ,|,|, followed|follow|VBN by|by|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN (|(|-LRB- 6.5|6.5|CD %|%|NN )|)|-RRB- and|and|CC lppAB|lppab|NN /|/|HYPH msbB|msbb|NN (|(|-LRB- 9.7|9.7|CD %|%|NN )|)|-RRB- mutants|mutant|NNS compared|compare|VBN to|to|IN the|the|DT control|control|NN splenocytes|splenocyte|NNS from|from|IN uninfected|uninfected|JJ mice|mouse|NNS .|.|. 
CD4|cd4|NN Treg|Treg|NNP cells|cell|NNS in|in|IN CD44high|cd44high|NN cells|cell|NNS from|from|IN the|the|DT spleens|spleen|NNS of|of|IN naive|naive|JJ C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS and|and|CC IL10|il10|NN −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS Splenocytes|splenocyte|NNS from|from|IN naive|naive|JJ C57BL|c57bl|NN /|/|HYPH 6|6|CD and|and|CC IL10|il10|NN −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD4|anti-cd4|JJ FITC|fitc|NN ,|,|, anti-CD25|anti-cd25|JJ APC|apc|NN and|and|CC anti-CD44|anti-cd44|JJ PE|pe|NN antibodies|antibody|NNS and|and|CC analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
R1|r1|NN cells|cell|NNS were|be|VBD gated|gate|VBN as|as|IN lymphocytes|lymphocyte|NNS and|and|CC R1|r1|NN +|+|SYM R2|r2|NN as|as|IN CD44high|cd44high|NN cells|cell|NNS ,|,|, while|while|IN R1|r1|NN +|+|SYM R3|r3|NN represented|represent|VBD CD44med|cd44me|VBN cells|cell|NNS (|(|-LRB- Figure|figure|NN 5A|5a|NN )|)|-RRB- .|.|. 
CD44high|cd44high|NN cells|cell|NNS contained|contain|VBD much|much|RB higher|higher|JJR levels|level|NNS of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS (|(|-LRB- 1.82|1.82|CD %|%|NN )|)|-RRB- ,|,|, compared|compare|VBN to|to|IN the|the|DT levels|level|NNS in|in|IN the|the|DT CD44med|cd44med|NN (|(|-LRB- 1.13|1.13|CD %|%|NN )|)|-RRB- and|and|CC control|control|NN splenocytes|splenocyte|NNS (|(|-LRB- 1.61|1.61|CD %|%|NN )|)|-RRB- of|of|IN naive|naive|JJ C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS (|(|-LRB- Figure|figure|NN 5B|5b|NN )|)|-RRB- .|.|. 
In|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS ,|,|, CD44high|cd44high|NN cells|cell|NNS Discussion|discussion|NN contained|contain|VBD much|much|RB higher|higher|JJR levels|level|NNS of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS (|(|-LRB- 2.3|2.3|CD %|%|NN )|)|-RRB- compared|compare|VBN to|to|IN the|the|DT levels|level|NNS in|in|IN CD44med|CD44med|NNP (|(|-LRB- 0.7|0.7|CD %|%|NN )|)|-RRB- and|and|CC control|control|NN splenocytes|splenocyte|NNS (|(|-LRB- 1.8|1.8|CD %|%|NN )|)|-RRB- (|(|-LRB- Figure|figure|NN 5C|5c|NN )|)|-RRB- .|.|. 
Higher|higher|JJR levels|level|NNS of|of|IN CD44high|cd44high|NN expression|expression|NN in|in|IN the|the|DT spleens|spleen|NNS of|of|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS Splenocytes|splenocyte|NNS from|from|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD and|and|CC IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN antibodies|antibody|NNS .|.|. 
The|the|DT splenocytes|splenocyte|NNS from|from|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD aged|aged|JJ mice|mouse|NNS expressed|express|VBD higher|higher|JJR levels|level|NNS of|of|IN CD44|cd44|NN than|than|IN did|do|VBD those|those|DT from|from|IN the|the|DT young|young|JJ mice|mouse|NNS (|(|-LRB- Figure|figure|NN 6A|6a|NN ;|;|: 2.06|2.06|CD %|%|NN versus|versus|CC 3.97|3.97|CD %|%|NN )|)|-RRB- .|.|. 
The|the|DT splenocytes|splenocyte|NNS from|from|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS expressed|express|VBD even|even|RB higher|higher|JJR levels|level|NNS of|of|IN CD44|cd44|NN than|than|IN did|do|VBD the|the|DT IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM young|young|JJ mice|mouse|NNS (|(|-LRB- Figure|figure|NN 6B|6b|NN ;|;|: 2.5|2.5|CD %|%|NN versus|versus|CC 13.6|13.6|CD %|%|NN )|)|-RRB- .|.|. 
We|we|PRP then|then|RB subcutaneously|subcutaneously|RB implanted|implant|VBN B16|b16|NN tumor|tumor|NN cells|cell|NNS in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS .|.|. 
After|after|IN 24|24|CD days|day|NNS ,|,|, mice|mouse|NNS with|with|IN bigger|bigger|JJR or|or|CC smaller|smaller|JJR tumors|tumor|NNS were|be|VBD killed|kill|VBN and|and|CC their|they|PRP$ splenocytes|splenocyte|NNS stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN antibodies|antibody|NNS .|.|. 
In|in|IN general|general|JJ ,|,|, the|the|DT mice|mouse|NNS having|have|VBG the|the|DT larger|larger|JJR tumors|tumor|NNS expressed|express|VBD higher|higher|JJR levels|level|NNS of|of|IN CD44high|cd44high|NN (|(|-LRB- 12.5|12.5|CD %|%|NN versus|versus|CC 8.4|8.4|CD %|%|NN )|)|-RRB- than|than|IN did|do|VBD animals|animal|NNS with|with|IN smaller|smaller|JJR tumors|tumor|NNS (|(|-LRB- Figure|figure|NN 6C|6c|NN )|)|-RRB- .|.|. 
Growth|growth|NN of|of|IN CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM cells|cell|NNS from|from|IN human|human|JJ liver|liver|NN tumors|tumor|NNS in|in|IN mice|mouse|NNS We|we|PRP sorted|sort|VBD CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM cells|cell|NNS from|from|IN human|human|JJ liver|liver|NN tumors|tumor|NNS and|and|CC grew|grow|VBD them|they|PRP in|in|IN DMEM|dmem|NN .|.|. 
After|after|IN expansion|expansion|NN of|of|IN the|the|DT cell|cell|NN colonies|colony|NNS in|in|IN 96|96|CD -|-|HYPH well|well|NN microtiter|microtiter|NN plates|plate|NNS ,|,|, the|the|DT cells|cell|NNS were|be|VBD transferred|transfer|VBN to|to|IN 25|25|CD -|-|HYPH cm2|cm2|NN cell|cell|NN culture|culture|NN flasks|flask|NNS .|.|. 
Six|six|CD days|day|NNS later|later|RB ,|,|, the|the|DT CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM tumor|tumor|NN cells|cell|NNS (|(|-LRB- 5|5|CD ×|×|SYM 105/100|105/100|CD µl|µl|NN )|)|-RRB- were|be|VBD injected|inject|VBN s.c.|s.c.|JJ into|into|IN BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS .|.|. 
The|the|DT mean|mean|JJ tumor|tumor|NN size|size|NN for|for|IN the|the|DT CD44|cd44|NN +|+|SYM group|group|NN was|be|VBD 1075|1075|CD +|+|SYM /|/|HYPH −|−|SYM 175|175|CD mm3|mm3|NN compared|compare|VBN to|to|IN 62|62|CD +|+|SYM /|/|HYPH −|−|SYM 42|42|CD mm3|mm3|NN for|for|IN the|the|DT CD44|cd44|NN −|−|HYPH group|group|NN on|on|IN day|day|NN 20|20|CD after|after|IN injection|injection|NN (|(|-LRB- Figure|figure|NN 7|7|CD )|)|-RRB- .|.|. 
These|these|DT data|datum|NNS indicated|indicate|VBD that|that|IN CD44|cd44|NN was|be|VBD required|require|VBN for|for|IN tumor|tumor|NN growth|growth|NN and|and|CC represented|represent|VBD an|a|DT important|important|JJ tumor|tumor|NN marker|marker|NN .|.|. 
The|the|DT exact|exact|JJ mechanism|mechanism|NN by|by|IN which|which|WDT Salmonella|salmonella|NN strains|strain|NNS result|result|VBP in|in|IN an|a|DT inhibition|inhibition|NN of|of|IN tumor|tumor|NN growth|growth|NN is|be|VBZ still|still|RB unclear|unclear|JJ .|.|. 
Some|some|DT earlier|earlier|JJR studies|study|NNS reported|report|VBD the|the|DT construction|construction|NN of|of|IN mutant|mutant|JJ strains|strain|NNS of|of|IN S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, such|such|JJ as|as|IN msbB|msbb|NN and|and|CC auxotrophic|auxotrophic|JJ mutants|mutant|NNS that|that|WDT were|be|VBD nonpathogenic|nonpathogenic|JJ for|for|IN mice|mouse|NNS ,|,|, pigs|pig|NNS ,|,|, and|and|CC humans|human|NNS .|.|. 
These|these|DT were|be|VBD also|also|RB demonstrated|demonstrate|VBN to|to|TO have|have|VB accumulated|accumulate|VBN 1000-fold|1000-fold|RB more|more|RBR in|in|IN tumors|tumor|NNS than|than|IN in|in|IN other|other|JJ organs|organ|NNS .|.|. 
However|however|RB ,|,|, the|the|DT clinical|clinical|JJ application|application|NN of|of|IN such|such|JJ strains|strain|NNS did|do|VBD not|not|RB successfully|successfully|RB curtail|curtail|VB tumor|tumor|NN growth|growth|NN 2|2|CD ,|,|, 40|40|CD .|.|. 
In|in|IN this|this|DT study|study|NN ,|,|, we|we|PRP showed|show|VBD that|that|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN did|do|VBD not|not|RB suppress|suppress|VB tumor|tumor|NN growth|growth|NN ,|,|, while|while|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN did|do|VBD somewhat|somewhat|RB slow|slow|JJ -|-|HYPH down|down|RP the|the|DT growth|growth|NN of|of|IN the|the|DT tumors|tumor|NNS compared|compare|VBN to|to|IN those|those|DT of|of|IN controls|control|NNS in|in|IN the|the|DT 24|24|CD days|day|NNS '|'|POS observation|observation|NN (|(|-LRB- Figure|figure|NN 1A|1a|NN )|)|-RRB- .|.|. 
Importantly|importantly|RB ,|,|, tumor|tumor|NN size|size|NN in|in|IN mice|mouse|NNS immunized|immunize|VBN with|with|IN either|either|DT of|of|IN the|the|DT mutants|mutant|NNS and|and|CC then|then|RB infected|infect|VBN with|with|IN the|the|DT WT|wt|NN bacteria|bacterium|NNS was|be|VBD significantly|significantly|RB reduced|reduce|VBN (|(|-LRB- Figure|figure|NN 1B|1b|NN )|)|-RRB- .|.|. 
These|these|DT data|datum|NNS indicated|indicate|VBD that|that|IN the|the|DT S.|S.|NNP Typhimurium|Typhimurium|NNP mutants|mutant|NNS that|that|WDT were|be|VBD deleted|delete|VBN for|for|IN the|the|DT msbB|msbb|NN and|and|CC lpp|lpp|NN genes|gene|NNS lost|lose|VBD this|this|DT tumor|tumor|NN repressor|repressor|NN function|function|NN ,|,|, and|and|CC LPS|lps|NN and|and|CC Lpp|lpp|NN were|be|VBD critical|critical|JJ for|for|IN S.|S.|NNP Typhimurium|Typhimurium|NNP 's|'s|POS anti-tumor|anti-tumor|JJ function|function|NN .|.|. 
The|the|DT CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS play|play|VBP a|a|DT crucial|crucial|JJ role|role|NN in|in|IN tumor|tumor|NN immune|immune|JJ pathogenesis|pathogenesis|NN ,|,|, and|and|CC they|they|PRP also|also|RB modulate|modulate|VBP immune|immune|JJ therapeutic|therapeutic|JJ efficacy|efficacy|NN 41|41|CD --|--|: 44|44|CD .|.|. 
We|we|PRP explored|explore|VBD the|the|DT mechanism|mechanism|NN (|(|-LRB- s|s|AFX )|)|-RRB- underlying|underlie|VBG an|a|DT S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH mediated|mediate|VBN ,|,|, anti-tumor|anti-tumor|JJ effect|effect|NN ,|,|, and|and|CC found|find|VBD that|that|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS from|from|IN spleens|spleen|NNS of|of|IN mice|mouse|NNS were|be|VBD significantly|significantly|RB decreased|decrease|VBN (|(|-LRB- 69|69|CD %|%|NN )|)|-RRB- in|in|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH infected|infect|VBN mice|mouse|NNS and|and|CC decreased|decrease|VBN by|by|IN 31|31|CD %|%|NN in|in|IN lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN -|-|HYPH infected|infect|VBN mice|mouse|NNS (|(|-LRB- Figure|figure|NN 2A|2a|NN )|)|-RRB- .|.|. 
This|this|DT decrease|decrease|NN in|in|IN Treg|Treg|NNP cell|cell|NN development|development|NN correlated|correlate|VBN with|with|IN the|the|DT decreased|decrease|VBN Foxp3|foxp3|NN expression|expression|NN in|in|IN the|the|DT splenocytes|splenocyte|NNS of|of|IN mice|mouse|NNS infected|infect|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP (|(|-LRB- Figure|figure|NN 2B|2b|NN )|)|-RRB- .|.|. 
LPS|lps|NN has|have|VBZ been|be|VBN shown|show|VBN to|to|TO reduce|reduce|VB expression|expression|NN of|of|IN Foxp3|foxp3|NN in|in|IN lymphocytes|lymphocyte|NNS 45|45|CD ,|,|, 46|46|CD .|.|. 
Our|we|PRP$ data|datum|NNS presented|present|VBN in|in|IN Figure|figure|NN 2A|2a|NN and|and|CC Figure|figure|NN 4B|4b|NN tend|tend|VBP to|to|TO suggest|suggest|VB that|that|IN the|the|DT expression|expression|NN of|of|IN CD44high|cd44high|NN on|on|IN T|t|NN cells|cell|NNS could|could|MD in|in|IN part|part|NN be|be|VB related|relate|VBN to|to|IN both|both|DT T|t|NN cell|cell|NN activation|activation|NN and|and|CC Treg|Treg|NNP cell|cell|NN population|population|NN .|.|. 
We|we|PRP must|must|MD emphasize|emphasize|VB here|here|RB that|that|WDT for|for|IN some|some|DT experiments|experiment|NNS we|we|PRP preferred|prefer|VBD to|to|TO use|use|VB out|out|RB -|-|HYPH bred|breed|VBN Swiss|swiss|JJ -|-|HYPH Webster|Webster|NNP over|over|IN in|in|IN -|-|HYPH bred|breed|VBN C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS as|as|IN the|the|DT latter|latter|JJ are|be|VBP more|more|RBR sensitive|sensitive|JJ to|to|IN S.|S.|NNP Typhimurium|Typhimurium|NNP infection|infection|NN ,|,|, since|since|IN as|as|RB little|little|JJ as|as|IN 50|50|CD cfu|cfu|NN resulted|result|VBD in|in|IN the|the|DT deaths|death|NNS of|of|IN 30|30|CD --|--|: 50|50|CD %|%|NN of|of|IN these|these|DT mice|mouse|NNS .|.|. 
Therefore|therefore|RB ,|,|, in|in|IN those|those|DT experiments|experiment|NNS in|in|IN which|which|WDT higher|higher|JJR doses|dose|NNS of|of|IN bacteria|bacterium|NNS were|be|VBD used|use|VBN ,|,|, we|we|PRP used|use|VBD Swiss|Swiss|NNP -|-|HYPH Webster|Webster|NNP mice|mouse|NNS .|.|. 
We|we|PRP should|should|MD cautiously|cautiously|RB interpret|interpret|VB data|datum|NNS as|as|IN different|different|JJ strains|strain|NNS of|of|IN mice|mouse|NNS might|might|MD behave|behave|VB differently|differently|RB to|to|IN S.|S.|NNP Typhimurium|Typhimurium|NNP infection|infection|NN as|as|IN it|it|PRP relates|relate|VBZ to|to|IN tumor|tumor|NN growth|growth|NN .|.|. 
S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH induced|induce|VBN CD8|CD8|NNP CTL|CTL|NNP and|and|CC NK|NK|NNP cells|cell|NNS can|can|MD kill|kill|VB tumor|tumor|NN cells|cell|NNS directly|directly|RB 47|47|CD --|--|: 49|49|CD .|.|. 
Likewise|likewise|RB ,|,|, S.|S.|NNP Typhimurium|Typhimurium|NNP promotes|promote|VBZ the|the|DT maturation|maturation|NN of|of|IN dendritic|dendritic|JJ cells|cell|NNS (|(|-LRB- DCs|dc|NNS )|)|-RRB- and|and|CC enhances|enhance|VBZ the|the|DT ability|ability|NN of|of|IN antigens|antigen|NNS to|to|TO present|present|VB to|to|IN DCs|dc|NNS 50|50|CD .|.|. 
It|it|PRP has|have|VBZ been|be|VBN shown|show|VBN that|that|IN splenic|splenic|JJ T|t|NN cells|cell|NNS are|be|VBP broadly|broadly|RB activated|activate|VBN in|in|IN the|the|DT host|host|NN later|later|RB during|during|IN Salmonella|salmonella|NN infection|infection|NN 51|51|CD .|.|. 
Further|further|RB ,|,|, salmonellae|salmonella|NNS -|-|HYPH induced|induce|VBN IL|il|NN -|-|HYPH 12|12|CD and|and|CC IFN|IFN|NNP -|-|HYPH γ|γ|SYM are|be|VBP two|two|CD critical|critical|JJ anti-tumor|anti-tumor|JJ cytokines|cytokine|NNS 52|52|CD ,|,|, and|and|CC IFNγ|ifnγ|NN -|-|HYPH producing|produce|VBG T|t|NN cells|cell|NNS are|be|VBP significantly|significantly|RB elevated|elevate|VBN after|after|IN primary|primary|JJ infection|infection|NN 53|53|CD .|.|. 
Our|we|PRP$ results|result|NNS showed|show|VBD that|that|IN CD4|cd4|NN ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM ,|,|, and|and|CC NK|NK|NNP cells|cell|NNS as|as|RB well|well|RB as|as|IN macrophages|macrophage|NNS were|be|VBD significantly|significantly|RB increased|increase|VBN in|in|IN the|the|DT tumors|tumor|NNS of|of|IN mice|mouse|NNS that|that|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP compared|compare|VBN to|to|IN those|those|DT animals|animal|NNS that|that|WDT were|be|VBD only|only|RB immunized|immunize|VBN or|or|CC given|give|VBN PBS|pbs|NN (|(|-LRB- Figure|figure|NN 3|3|CD )|)|-RRB- .|.|. 
It|it|PRP is|be|VBZ known|know|VBN that|that|IN CD4|cd4|NN and|and|CC NK|NK|NNP cells|cell|NNS could|could|MD inhibit|inhibit|VB tumor|tumor|NN growth|growth|NN 54|54|CD ,|,|, 55|55|CD ,|,|, but|but|CC the|the|DT function|function|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM cells|cell|NNS in|in|IN modulating|modulate|VBG the|the|DT growth|growth|NN of|of|IN tumors|tumor|NNS is|be|VBZ not|not|RB clear|clear|JJ .|.|. 
Based|base|VBN on|on|IN our|we|PRP$ data|datum|NNS ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM cells|cell|NNS appeared|appear|VBD to|to|TO be|be|VB recruited|recruit|VBN into|into|IN tumors|tumor|NNS but|but|CC they|they|PRP might|might|MD not|not|RB inhibit|inhibit|VB tumor|tumor|NN growth|growth|NN directly|directly|RB but|but|CC might|might|MD prevent|prevent|VB suppressor|suppressor|NN CD4|cd4|NN T|t|NN cells|cell|NNS to|to|TO enter|enter|VB tumors|tumor|NNS .|.|. 
We|we|PRP found|find|VBD CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM cell|cell|NN numbers|number|NNS to|to|TO be|be|VB lower|lower|JJR in|in|IN smaller|smaller|JJR size|size|NN tumors|tumor|NNS than|than|IN in|in|IN bigger|bigger|JJR size|size|NN tumors|tumor|NNS after|after|IN infection|infection|NN of|of|IN mice|mouse|NNS with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP (|(|-LRB- data|datum|NNS no|no|DT shown|show|VBN )|)|-RRB- .|.|. 
Further|further|RB ,|,|, IFN|IFN|NNP -|-|HYPH γ|γ|SYM producing|produce|VBG cells|cell|NNS were|be|VBD significantly|significantly|RB increased|increase|VBN in|in|IN tumors|tumor|NNS that|that|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN and|and|CC then|then|RB challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP ,|,|, suggesting|suggest|VBG that|that|IN Th1|th1|NN response|response|NN might|might|MD be|be|VB important|important|JJ for|for|IN the|the|DT anti-tumor|anti-tumor|JJ response|response|NN .|.|. 
CD44|cd44|NN has|have|VBZ been|be|VBN shown|show|VBN to|to|TO be|be|VB highly|highly|RB expressed|express|VBN in|in|IN many|many|JJ tumor|tumor|NN cells|cell|NNS 56|56|CD such|such|JJ as|as|IN colorectal|colorectal|JJ cancer|cancer|NN stem|stem|NN cells|cell|NNS ,|,|, and|and|CC expression|expression|NN of|of|IN CD44|cd44|NN in|in|IN immortalized|immortalize|VBN cancer|cancer|NN cell|cell|NN lines|line|NNS is|be|VBZ of|of|IN functional|functional|JJ importance|importance|NN 57|57|CD ,|,|, 58|58|CD .|.|. 
CD44|cd44|NN has|have|VBZ recently|recently|RB been|be|VBN shown|show|VBN to|to|TO be|be|VB an|a|DT important|important|JJ marker|marker|NN of|of|IN cancer|cancer|NN stem|stem|NN cells|cell|NNS or|or|CC cancer|cancer|NN -|-|HYPH initiating|initiate|VBG cells59|cells59|NN ,|,|, 60|60|CD .|.|. 
Both|both|DT CD44|cd44|NN and|and|CC its|its|PRP$ variant|variant|NN (|(|-LRB- vCD44|vcd44|NN )|)|-RRB- when|when|WRB expressed|express|VBN in|in|IN cancer|cancer|NN cells|cell|NNS ,|,|, correlate|correlate|VB strongly|strongly|RB with|with|IN invasiveness|invasiveness|NN ,|,|, metastasis|metastasis|NN ,|,|, and|and|CC tumor|tumor|NN growth|growth|NN 61|61|CD ,|,|, 62|62|CD .|.|. 
Likewise|likewise|RB ,|,|, CD44|cd44|NN +|+|SYM cancer|cancer|NN stem|stem|NN cells|cell|NNS have|have|VBP been|be|VBN shown|show|VBN to|to|TO have|have|VB enhanced|enhance|VBN potential|potential|NN for|for|IN proliferation|proliferation|NN ,|,|, migration|migration|NN ,|,|, and|and|CC invasion|invasion|NN 63|63|CD .|.|. 
We|we|PRP noted|note|VBD that|that|IN CD44|cd44|NN was|be|VBD expressed|express|VBN at|at|IN a|a|DT significant|significant|JJ level|level|NN in|in|IN B16|b16|NN tumor|tumor|NN cells|cell|NNS .|.|. 
However|however|RB ,|,|, its|its|PRP$ expression|expression|NN was|be|VBD decreased|decrease|VBN in|in|IN B16|b16|NN tumor|tumor|NN cells|cell|NNS infected|infect|VBN with|with|IN S.|S.|NNP Typhumirum|Typhumirum|NNP ,|,|, albeit|albeit|IN to|to|IN different|different|JJ levels|level|NNS with|with|IN WT|wt|NN versus|versus|IN the|the|DT mutants|mutant|NNS (|(|-LRB- Figure|figure|NN 4A|4a|NN )|)|-RRB- .|.|. 
WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP strains|strain|NNS used|use|VBN in|in|IN this|this|DT study|study|NN did|do|VBD not|not|RB only|only|RB directly|directly|RB decrease|decrease|VB CD44|cd44|NN expression|expression|NN of|of|IN tumor|tumor|NN cells|cell|NNS in|in|FW vitro|vitro|FW but|but|CC also|also|RB CD44|cd44|NN expression|expression|NN of|of|IN lymphocytes|lymphocyte|NNS in|in|FW vivo|vivo|FW (|(|-LRB- Figure|figure|NN 4B|4b|NN )|)|-RRB- .|.|. 
It|it|PRP has|have|VBZ been|be|VBN shown|show|VBN in|in|IN the|the|DT literature|literature|NN that|that|WDT LPS|lps|NN induces|induce|VBZ CD44|cd44|NN expression|expression|NN in|in|IN monocytes|monocyte|NNS 64,65|64,65|CD ,|,|, however|however|RB ,|,|, then|then|RB why|why|WRB did|do|VBD CD44|cd44|NN cells|cell|NNS decrease|decrease|VBP after|after|IN S.|S.|NNP Typhimurium|Typhimurium|NNP infection|infection|NN in|in|IN our|we|PRP$ study|study|NN ?|?|. 
We|we|PRP believe|believe|VBP that|that|IN activation|activation|NN -|-|HYPH induced|induce|VBN death|death|NN of|of|IN splenic|splenic|JJ cells|cell|NNS could|could|MD contribute|contribute|VB to|to|IN the|the|DT observed|observe|VBN CD44|cd44|NN cell|cell|NN loss|loss|NN during|during|IN S.|S.|NNP Typhimurium|Typhimurium|NNP infection|infection|NN .|.|. 
The|the|DT role|role|NN of|of|IN CD44|cd44|NN expression|expression|NN in|in|IN the|the|DT development|development|NN of|of|IN Treg|Treg|NNP cells|cell|NNS has|have|VBZ been|be|VBN reported|report|VBN 66|66|CD ,|,|, and|and|CC therefore|therefore|RB ,|,|, we|we|PRP analyzed|analyze|VBD CD44high|cd44high|NN cells|cell|NNS of|of|IN spleens|spleen|NNS for|for|IN the|the|DT presence|presence|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS (|(|-LRB- Figure|figure|NN 5A|5a|NN )|)|-RRB- .|.|. 
We|we|PRP found|find|VBD that|that|IN CD44high|cd44high|NN cells|cell|NNS contained|contain|VBD much|much|RB higher|higher|JJR levels|level|NNS of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS than|than|IN did|do|VBD the|the|DT CD44med|cd44me|VBN cells|cell|NNS in|in|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS (|(|-LRB- Figure|figure|NN 5B|5b|NN )|)|-RRB- .|.|. 
Likewise|likewise|RB ,|,|, CD44high|cd44high|NN cells|cell|NNS contained|contain|VBD much|much|RB higher|higher|JJR levels|level|NNS of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM T|t|NN cells|cell|NNS than|than|IN did|do|VBD CD44med|CD44med|NNP reg|reg|NN cells|cell|NNS in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM mice|mouse|NNS (|(|-LRB- Figure|figure|NN 5C|5c|NN )|)|-RRB- .|.|. 
IL|il|NN -|-|HYPH 10|10|CD has|have|VBZ been|be|VBN shown|show|VBN to|to|TO be|be|VB associated|associate|VBN with|with|IN both|both|DT immune|immune|JJ stimulation|stimulation|NN and|and|CC suppression|suppression|NN of|of|IN tumor|tumor|NN growth|growth|NN .|.|. 
A|a|DT high|high|JJ incidence|incidence|NN of|of|IN colorectal|colorectal|JJ adenocarcinomas|adenocarcinoma|NNS (|(|-LRB- 60|60|CD %|%|NN )|)|-RRB- was|be|VBD observed|observe|VBN in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS .|.|. 
The|the|DT IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM mouse|mouse|NN is|be|VBZ a|a|DT model|model|NN for|for|IN colon|colon|NN cancer|cancer|NN ,|,|, which|which|WDT develops|develop|VBZ via|via|IN the|the|DT dysphasia|dysphasia|NN sequence|sequence|NN ,|,|, a|a|DT process|process|NN similar|similar|JJ to|to|IN that|that|DT seen|see|VBN in|in|IN clinical|clinical|JJ inflammatory|inflammatory|JJ bowel|bowel|NN disease|disease|NN -|-|HYPH associated|associate|VBN cancer|cancer|NN 67|67|CD ,|,|, 68|68|CD .|.|. 
Therefore|therefore|RB ,|,|, we|we|PRP next|next|RB examined|examine|VBD IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS and|and|CC found|find|VBD increasingly|increasingly|RB higher|higher|JJR CD44high|cd44high|NN levels|level|NNS in|in|IN the|the|DT splenocytes|splenocyte|NNS of|of|IN aged|aged|JJ IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM mice|mouse|NNS than|than|IN young|young|JJ mice|mouse|NNS (|(|-LRB- Figure|figure|NN 6B|6b|NN )|)|-RRB- .|.|. 
Moreover|moreover|RB ,|,|, when|when|WRB we|we|PRP injected|inject|VBD B16|b16|NN tumor|tumor|NN cells|cell|NNS s.c.|s.c.|JJ in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS and|and|CC selected|select|VBD a|a|DT few|few|JJ mice|mouse|NNS having|have|VBG either|either|CC large|large|JJ or|or|CC small|small|JJ tumors|tumor|NNS ,|,|, we|we|PRP found|find|VBD a|a|DT higher|higher|JJR expression|expression|NN of|of|IN CD44high|cd44high|NN in|in|IN the|the|DT spleens|spleen|NNS of|of|IN mice|mouse|NNS having|have|VBG larger|larger|JJR tumors|tumor|NNS than|than|IN in|in|IN those|those|DT with|with|IN smaller|smaller|JJR tumors|tumor|NNS (|(|-LRB- Figure|figure|NN 6C|6c|NN )|)|-RRB- .|.|. 
Aged|age|VBN mice|mouse|NNS have|have|VBP reportedly|reportedly|RB expressed|express|VBN higher|higher|JJR levels|level|NNS of|of|IN CD44high|cd44high|NN than|than|IN do|do|VB the|the|DT younger|younger|JJR mice|mouse|NNS (|(|-LRB- about|about|IN two|two|CD fold|fold|RB )|)|-RRB- (|(|-LRB- Figure|figure|NN 6A|6a|NN )|)|-RRB- .|.|. 
For|for|IN example|example|NN ,|,|, CD44high|cd44high|NN expression|expression|NN was|be|VBD greater|greater|JJR in|in|IN aged|aged|JJ SPA|spa|NN -|-|HYPH 1|1|CD −|−|SYM /|/|HYPH −|−|SYM mice|mouse|NNS developing|develop|VBG late|late|JJ onset|onset|NN of|of|IN myeloid|myeloid|JJ leukemia|leukemia|NN 69|69|CD .|.|. 
Thus|thus|RB ,|,|, CD44high|cd44high|NN cells|cell|NNS may|may|MD contribute|contribute|VB to|to|IN tumor|tumor|NN occurrence|occurrence|NN and|and|CC development|development|NN .|.|. 
Therefore|therefore|RB ,|,|, the|the|DT relationship|relationship|NN of|of|IN CD44high|cd44high|NN expression|expression|NN of|of|IN lymphocytes|lymphocyte|NNS with|with|IN that|that|DT of|of|IN tumor|tumor|NN growth|growth|NN should|should|MD be|be|VB further|further|RB studied|study|VBN in|in|IN detail|detail|NN .|.|. 
To|to|TO confirm|confirm|VB that|that|IN CD44|cd44|NN is|be|VBZ important|important|JJ for|for|IN tumor|tumor|NN growth|growth|NN ,|,|, we|we|PRP sorted|sort|VBD CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM cells|cell|NNS from|from|IN human|human|JJ liver|liver|NN tumor|tumor|NN samples|sample|NNS .|.|. 
We|we|PRP found|find|VBD CD44|cd44|NN +|+|SYM tumor|tumor|NN cells|cell|NNS grew|grow|VBD much|much|RB faster|faster|RBR compared|compare|VBN to|to|IN CD44|cd44|NN −|−|SYM tumor|tumor|NN cells|cell|NNS in|in|FW vivo|vivo|FW (|(|-LRB- Figure|figure|NN 7|7|CD )|)|-RRB- ;|;|: however|however|RB ,|,|, their|they|PRP$ growth|growth|NN rates|rate|NNS were|be|VBD quite|quite|RB similar|similar|JJ in|in|FW vitro|vitro|FW .|.|. 
These|these|DT data|datum|NNS suggested|suggest|VBD to|to|IN us|we|PRP a|a|DT dependence|dependence|NN on|on|IN CD44|cd44|NN in|in|IN tumor|tumor|NN development|development|NN in|in|FW vivo|vivo|FW .|.|. 
CD44|cd44|NN is|be|VBZ a|a|DT cell|cell|NN surface|surface|NN proteoglycan|proteoglycan|NN ,|,|, thought|think|VBD to|to|TO be|be|VB involved|involve|VBN in|in|IN cell|cell|NN -|-|HYPH to|to|IN -|-|HYPH cell|cell|NN adhesion|adhesion|NN and|and|CC cell|cell|NN matrix|matrix|NN -|-|HYPH adhesion|adhesion|NN interactions|interaction|NNS ,|,|, lymphocyte|lymphocyte|NN activation|activation|NN ,|,|, and|and|CC homing|homing|NN and|and|CC cell|cell|NN migration|migration|NN .|.|. 
We|we|PRP believe|believe|VBP S.|S.|NNP Typhimurium|Typhimurium|NNP suppresses|suppress|VBZ tumor|tumor|NN growth|growth|NN through|through|IN various|various|JJ direct|direct|JJ and|and|CC indirect|indirect|JJ pathways|pathway|NNS ,|,|, and|and|CC that|that|IN our|we|PRP$ data|datum|NNS provide|provide|VBP indication|indication|NN that|that|IN it|it|PRP directly|directly|RB down|down|RB -|-|HYPH regulated|regulate|VBN the|the|DT expression|expression|NN of|of|IN CD44|cd44|NN in|in|IN tumors|tumor|NNS in|in|FW vitro|vitro|FW and|and|CC in|in|IN lymphocytes|lymphocyte|NNS in|in|FW vivo|vivo|FW .|.|. 
Further|further|RB ,|,|, S.|S.|NNP Typhimurium|Typhimurium|NNP seemed|seem|VBD to|to|TO enhance|enhance|VB the|the|DT anti-tumor|anti-tumor|JJ response|response|NN by|by|IN reducing|reduce|VBG the|the|DT numbers|number|NNS of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS .|.|. 
We|we|PRP noted|note|VBD that|that|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS induced|induce|VBD a|a|DT very|very|RB low|low|JJ Th1|th1|NN response|response|NN in|in|IN mice|mouse|NNS ,|,|, including|include|VBG minimal|minimal|JJ interferon|interferon|NN (|(|-LRB- IFN|ifn|NN )|)|-RRB- -|-|HYPH γ|γ|SYM and|and|CC TNF|tnf|NN -|-|HYPH α|α|NN production|production|NN and|and|CC higher|higher|JJR levels|level|NNS of|of|IN IgG1|igg1|NN antibody|antibody|NN production|production|NN ,|,|, compared|compare|VBN to|to|IN that|that|DT in|in|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP -|-|HYPH treated|treat|VBN mice|mouse|NNS which|which|WDT exhibited|exhibit|VBD the|the|DT opposite|opposite|JJ trend|trend|NN 17|17|CD ,|,|, 70|70|CD .|.|. 
These|these|DT data|datum|NNS suggested|suggest|VBD that|that|IN the|the|DT Th1|th1|NN -|-|HYPH induced|induce|VBN cellular|cellular|JJ responses|response|NNS were|be|VBD more|more|RBR important|important|JJ than|than|IN the|the|DT antibody|antibody|NN (|(|-LRB- humoral|humoral|JJ )|)|-RRB- responses|response|NNS in|in|IN anti-tumor|anti-tumor|JJ immune|immune|JJ mechanisms|mechanism|NNS .|.|. 
Would|would|MD such|such|JJ mutants|mutant|NNS accordingly|accordingly|RB be|be|VB beneficial|beneficial|JJ in|in|IN controlling|control|VBG tumor|tumor|NN growth|growth|NN in|in|IN humans|human|NNS ?|?|. 
The|the|DT advantage|advantage|NN of|of|IN immunizing|immunize|VBG first|first|RB with|with|IN the|the|DT mutants|mutant|NNS is|be|VBZ that|that|IN subsequently|subsequently|RB higher|higher|JJR doses|dose|NNS of|of|IN the|the|DT WT|wt|NN bacteria|bacterium|NNS can|can|MD be|be|VB given|give|VBN without|without|IN danger|danger|NN of|of|IN inducing|induce|VBG sepsis|sepsis|NN in|in|IN the|the|DT host|host|NN .|.|. 
Certainly|certainly|RB ,|,|, this|this|DT adjunct|adjunct|JJ therapy|therapy|NN would|would|MD then|then|RB seem|seem|VB to|to|TO be|be|VB advantageous|advantageous|JJ ,|,|, as|as|IN the|the|DT virulence|virulence|NN of|of|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP is|be|VBZ likely|likely|JJ seems|seem|VBZ to|to|TO be|be|VB essential|essential|JJ in|in|IN retarding|retard|VBG tumor|tumor|NN growth|growth|NN in|in|IN the|the|DT host|host|NN .|.|. 
The|the|DT lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS in|in|IN general|general|JJ and|and|CC the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN in|in|IN particular|particular|JJ caused|cause|VBD a|a|DT significantly|significantly|RB increase|increase|NN in|in|IN the|the|DT down|down|JJ regulation|regulation|NN of|of|IN CD44|cd44|NN and|and|CC the|the|DT number|number|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS ,|,|, when|when|WRB compared|compare|VBN to|to|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP in|in|IN the|the|DT splenocytes|splenocyte|NNS of|of|IN infected|infected|JJ mice|mouse|NNS (|(|-LRB- Figure|figure|NN 2|2|CD and|and|CC Figure|figure|NN 4|4|CD )|)|-RRB- .|.|. 
These|these|DT data|datum|NNS tend|tend|VBP to|to|TO suggest|suggest|VB the|the|DT role|role|NN of|of|IN LPS|lps|NN and|and|CC Lpp|lpp|NN in|in|IN the|the|DT down|down|JJ regulation|regulation|NN of|of|IN CD44|cd44|NN and|and|CC Treg|Treg|NNP cells|cell|NNS ,|,|, with|with|IN an|a|DT ultimate|ultimate|JJ reduction|reduction|NN in|in|IN the|the|DT tumor|tumor|NN suppression|suppression|NN function|function|NN of|of|IN lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS (|(|-LRB- Figure|figure|NN 1|1|CD )|)|-RRB- .|.|. 
An|a|DT earlier|earlier|JJR study|study|NN by|by|IN Low|Low|NNP et|et|FW al.|al.|FW (|(|-LRB- 2|2|CD )|)|-RRB- reported|report|VBD that|that|IN S.|S.|NNP Typhimurium|Typhimurium|NNP msbB|msbB|NNP mutant|mutant|NN did|do|VBD not|not|RB alter|alter|VB anti-tumor|anti-tumor|JJ activity|activity|NN against|against|IN s.c.|s.c.|JJ implanted|implant|VBN B16F10|b16f10|NN melanomas|melanoma|NNS 2|2|CD .|.|. 
Therefore|therefore|RB ,|,|, Lpp|lpp|NN might|might|MD be|be|VB more|more|RBR important|important|JJ in|in|IN inducing|induce|VBG an|a|DT anti-tumor|anti-tumor|JJ effect|effect|NN than|than|IN LPS|lps|NN and|and|CC would|would|MD be|be|VB studied|study|VBN in|in|IN the|the|DT future|future|NN .|.|. 
Recently|recently|RB ,|,|, it|it|PRP was|be|VBD demonstrated|demonstrate|VBN that|that|IN anti-tumor|anti-tumor|JJ activity|activity|NN of|of|IN Salmonella|salmonella|NN strains|strain|NNS correlated|correlate|VBN with|with|IN decreased|decrease|VBN angiogenesis|angiogenesis|NN and|and|CC increased|increase|VBD tissue|tissue|NN necrosis|necrosis|NN within|within|IN the|the|DT tumor|tumor|NN tissue|tissue|NN 71|71|CD .|.|. 
Their|they|PRP$ results|result|NNS showed|show|VBD that|that|IN Salmonella|Salmonella|NNP could|could|MD directly|directly|RB inhibit|inhibit|VB tumor|tumor|NN growth|growth|NN .|.|. 
Our|we|PRP$ data|datum|NNS pointed|point|VBD to|to|IN the|the|DT fact|fact|NN that|that|IN S.|S.|NNP Typhimurium|Typhimurium|NNP did|do|VBD not|not|RB only|only|RB directly|directly|RB inhibit|inhibit|VB tumor|tumor|NN growth|growth|NN but|but|CC also|also|RB inhibited|inhibit|VBN tumor|tumor|NN growth|growth|NN through|through|IN indirectly|indirectly|RB pathways|pathway|NNS including|include|VBG changes|change|NNS in|in|IN the|the|DT host|host|NN immune|immune|JJ system|system|NN ,|,|, specifically|specifically|RB by|by|IN down|down|RB -|-|HYPH regulating|regulate|VBG CD44|cd44|NN and|and|CC CD4|cd4|NN T|t|NN reg|reg|NN cell|cell|NN numbers|number|NNS in|in|IN the|the|DT spleen|spleen|NN of|of|IN mice|mouse|NNS .|.|. 
In|in|IN this|this|DT study|study|NN ,|,|, we|we|PRP used|use|VBD S.|S.|NNP Typhimurium|Typhimurium|NNP mutants|mutant|NNS lppAB|lppab|NN /|/|SYM msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN as|as|IN adjuncts|adjunct|NNS to|to|TO help|help|VB WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP suppress|suppress|VB tumor|tumor|NN cell|cell|NN growth|growth|NN .|.|. 
We|we|PRP found|find|VBD tumor|tumor|NN growth|growth|NN suppression|suppression|NN by|by|IN 88|88|CD %|%|NN in|in|IN mice|mouse|NNS that|that|WDT were|be|VBD first|first|JJ immunized|immunize|VBN with|with|IN the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN and|and|CC then|then|RB challenged|challenge|VBN with|with|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN of|of|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP .|.|. 
Our|we|PRP$ data|datum|NNS provided|provide|VBN possible|possible|JJ mechanisms|mechanism|NNS by|by|IN which|which|WDT S.|S.|NNP Typhimurium|Typhimurium|NNP could|could|MD modulate|modulate|VB tumor|tumor|NN growth|growth|NN and|and|CC include|include|VBP down|down|RP regulation|regulation|NN of|of|IN CD44|cd44|NN and|and|CC CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cell|cell|NN expression|expression|NN ,|,|, which|which|WDT would|would|MD ,|,|, in|in|IN turn|turn|NN ,|,|, up|up|RB -|-|HYPH regulate|regulate|VB host|host|NN immune|immune|JJ responses|response|NNS to|to|TO inhibit|inhibit|VB tumor|tumor|NN growth|growth|NN that|that|WDT is|be|VBZ largely|largely|RB LPS|lps|NN -|-|HYPH and|and|CC lipoprotein|lipoprotein|NN -|-|HYPH dependent|dependent|JJ .|.|. 
The|the|DT use|use|NN of|of|IN mutant|mutant|NN S.|S.|NNP Typhimurium|Typhimurium|NNP to|to|TO suppress|suppress|VB tumor|tumor|NN growth|growth|NN might|might|MD provide|provide|VB attractive|attractive|JJ alternatives|alternative|NNS for|for|IN the|the|DT development|development|NN of|of|IN immunotherapy|immunotherapy|NN for|for|IN cancer|cancer|NN .|.|. 
Acknowledgements|acknowledgement|NNS We|we|PRP thank|thank|VBP Ms.|Ms.|NNP Mardelle|Mardelle|NNP Susman|Susman|NNP for|for|IN assisting|assist|VBG in|in|IN manuscript|manuscript|NN preparation|preparation|NN .|.|. 
This|this|DT study|study|NN was|be|VBD supported|support|VBN by|by|IN NIH|NIH|NNP grant|grant|NN AI064389|ai064389|NN to|to|IN A.|A.|NNP K.|K.|NNP Chopra|Chopra|NNP .|.|. 
1|1|LS .|.|. 
Pawelek|Pawelek|NNP JM|JM|NNP ,|,|, Low|Low|NNP KB|KB|NNP ,|,|, Bermudes|Bermudes|NNP D.|D.|NNP Tumor|Tumor|NNP -|-|HYPH targeted|target|VBN Salmonella|salmonella|NN as|as|IN a|a|DT novel|novel|JJ anticancer|anticancer|JJ vector|vector|NN .|.|. 
Cancer|Cancer|NNP Res|Res|NNP .|.|. 
1997|1997|CD ;|;|: 57|57|CD (|(|-LRB- 20|20|CD )|)|-RRB- :|:|: 4537|4537|CD --|--|: 4544|4544|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9377566|9377566|CD ]|]|-RRB- 2|2|LS .|.|. 
Low|low|JJ KB|kb|NN ,|,|, Ittensohn|Ittensohn|NNP M|M|NNP ,|,|, Le|Le|NNP T|T|NNP ,|,|, Platt|Platt|NNP J|J|NNP ,|,|, Sodi|Sodi|NNP S|S|NNP ,|,|, Amoss|Amoss|NNP M|M|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Lipid|lipid|NN A|a|NN mutant|mutant|NN Salmonella|salmonella|NN with|with|IN suppressed|suppress|VBN virulence|virulence|NN and|and|CC TNFalpha|tnfalpha|NN induction|induction|NN retain|retain|VBP tumor|tumor|NN -|-|HYPH targeting|targeting|NN in|in|FW vivo|vivo|FW .|.|. 
Nat|nat|JJ Biotechnol|Biotechnol|NNP .|.|. 
1999|1999|CD ;|;|: 17|17|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 37|37|CD --|--|: 41|41|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9920266|9920266|CD ]|]|-RRB- 3|3|LS .|.|. 
Simmers|simmer|VBZ TA|ta|NN ,|,|, Mijnhout|Mijnhout|NNP GS|GS|NNP ,|,|, Van|Van|NNP Meyel|Meyel|NNP JJ|JJ|NNP .|.|. 
Salmonellosis|salmonellosis|NN :|:|: an|a|DT unusual|unusual|JJ complication|complication|NN of|of|IN hepatocellular|hepatocellular|JJ carcinoma|carcinoma|NN .|.|. 
Scand|Scand|NNP J|J|NNP Gastroenterol|Gastroenterol|NNP .|.|. 
1997|1997|CD ;|;|: 32|32|CD (|(|-LRB- 11|11|CD )|)|-RRB- :|:|: 1180|1180|CD --|--|: 1182|1182|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9399402|9399402|CD ]|]|-RRB- 4|4|LS .|.|. 
Noguerado|Noguerado|NNP A|A|NNP ,|,|, Cabanyes|Cabanyes|NNP J|J|NNP ,|,|, Vivancos|Vivancos|NNP J|J|NNP ,|,|, Navarro|Navarro|NNP E|E|NNP ,|,|, Lopez|Lopez|NNP F|F|NNP ,|,|, Isasia|Isasia|NNP T|T|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Abscess|abscess|NN caused|cause|VBN by|by|IN Salmonella|salmonella|NN enteritidis|enteritidi|NNS within|within|IN a|a|DT glioblastoma|glioblastoma|NN multiforme|multiforme|NN .|.|. 
J|j|NN Infect|infect|NN .|.|. 
1987|1987|CD ;|;|: 15|15|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 61|61|CD --|--|: 63|63|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2822812|2822812|CD ]|]|-RRB- 5|5|CD .|.|. 
Rodriguez|Rodriguez|NNP RE|re|NN ,|,|, Valero|Valero|NNP V|V|NNP ,|,|, Watanakunakorn|Watanakunakorn|NNP C.|C.|NNP Salmonella|Salmonella|NNP focal|focal|JJ intracranial|intracranial|JJ infections|infection|NNS :|:|: review|review|NN of|of|IN the|the|DT world|world|NN literature|literature|NN (|(|-LRB- 1884|1884|CD --|--|: 1984|1984|CD )|)|-RRB- and|and|CC report|report|NN of|of|IN an|a|DT unusual|unusual|JJ case|case|NN .|.|. 
Rev|Rev|NNP Infect|Infect|NNP Dis|Dis|NNP .|.|. 
1986|1986|CD ;|;|: 8|8|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 31|31|CD --|--|: 41|41|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 3513285|3513285|CD ]|]|-RRB- 6|6|CD .|.|. 
Pawelek|Pawelek|NNP JM|JM|NNP ,|,|, Low|Low|NNP KB|KB|NNP ,|,|, Bermudes|Bermudes|NNP D.|D.|NNP Bacteria|bacterium|NNS as|as|IN tumour|tumour|NN -|-|HYPH targeting|targeting|NN vectors|vector|NNS .|.|. 
Lancet|Lancet|NNP Oncol|Oncol|NNP .|.|. 
2003|2003|CD ;|;|: 4|4|CD (|(|-LRB- 9|9|CD )|)|-RRB- :|:|: 548|548|CD --|--|: 556|556|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12965276|12965276|CD ]|]|-RRB- 7|7|CD .|.|. 
Pawelek|Pawelek|NNP JM|JM|NNP ,|,|, Sodi|Sodi|NNP S|S|NNP ,|,|, Chakraborty|Chakraborty|NNP AK|AK|NNP ,|,|, Platt|Platt|NNP JT|JT|NNP ,|,|, Miller|Miller|NNP S|S|NNP ,|,|, Holden|Holden|NNP DW|DW|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Salmonella|salmonella|NN pathogenicity|pathogenicity|NN island|island|NN -|-|HYPH 2|2|CD and|and|CC anticancer|anticancer|JJ activity|activity|NN in|in|IN mice|mouse|NNS .|.|. 
Cancer|Cancer|NNP Gene|Gene|NNP Ther|Ther|NNP .|.|. 
2002|2002|CD ;|;|: 9|9|CD (|(|-LRB- 10|10|CD )|)|-RRB- :|:|: 813|813|CD --|--|: 818|818|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12224021|12224021|CD ]|]|-RRB- 8|8|CD .|.|. 
Jain|Jain|NNP RK|RK|NNP ,|,|, Forbes|Forbes|NNP NS|NS|NNP .|.|. 
Can|can|MD engineered|engineer|VBN bacteria|bacterium|NNS help|help|VBP control|control|VB cancer|cancer|NN ?|?|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 2001|2001|CD ;|;|, 98|98|CD (|(|-LRB- 26|26|CD )|)|-RRB- :|:|: 14748|14748|CD --|--|: 14750|14750|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11752416|11752416|CD ]|]|-RRB- 9|9|CD .|.|. 
Galan|Galan|NNP JE|JE|NNP ,|,|, Curtiss|Curtiss|NNP R|r|NN 3rd|3rd|NN .|.|. 
Cloning|cloning|NN and|and|CC molecular|molecular|JJ characterization|characterization|NN of|of|IN genes|gene|NNS whose|whose|WP$ products|product|NNS allow|allow|VBP Salmonella|Salmonella|NNP typhimurium|typhimurium|NN to|to|TO penetrate|penetrate|VB tissue|tissue|NN culture|culture|NN cells|cell|NNS .|.|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 1989|1989|CD ;|;|: 86|86|CD (|(|-LRB- 16|16|CD )|)|-RRB- :|:|: 6383|6383|CD --|--|: 6387|6387|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2548211|2548211|CD ]|]|-RRB- 10|10|CD .|.|. 
Evans|Evans|NNP ME|ME|NNP ,|,|, Pollack|Pollack|NNP M.|M.|NNP Effect|Effect|NNP of|of|IN antibiotic|antibiotic|JJ class|class|NN and|and|CC concentration|concentration|NN on|on|IN the|the|DT release|release|NN of|of|IN lipopolysaccharide|lipopolysaccharide|NN from|from|IN Escherichia|Escherichia|NNP coli|coli|NNP .|.|. 
J|j|NN Infect|infect|NN Dis|dis|NN .|.|. 
1993|1993|CD ;|;|: 167|167|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 1336|1336|CD --|--|: 1343|1343|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 8501323|8501323|CD ]|]|-RRB- 11|11|CD .|.|. 
Kohler|Kohler|NNP J|J|NNP ,|,|, Heumann|Heumann|NNP D|D|NNP ,|,|, Garotta|Garotta|NNP G|G|NNP ,|,|, LeRoy|LeRoy|NNP D|D|NNP ,|,|, Bailat|Bailat|NNP S|S|NNP ,|,|, Barras|Barras|NNP C|C|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
IFN|ifn|NN -|-|HYPH gamma|gamma|NN involvement|involvement|NN in|in|IN the|the|DT severity|severity|NN of|of|IN gram|gram|NN -|-|HYPH negative|negative|JJ infections|infection|NNS in|in|IN mice|mouse|NNS .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1993|1993|CD ;|;|: 151|151|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 916|916|CD --|--|: 921|921|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 8335919|8335919|CD ]|]|-RRB- 12|12|CD .|.|. 
Galdiero|Galdiero|NNP M|M|NNP ,|,|, De|De|NNP Martino|Martino|NNP L|L|NNP ,|,|, Marcatili|Marcatili|NNP A|A|NNP ,|,|, Nuzzo|Nuzzo|NNP I|I|PRP ,|,|, Vitiello|Vitiello|NNP M|M|NNP ,|,|, Cipollaro|Cipollaro|NNP de|de|NNP l'Ero|l'Ero|NNP G.|G.|NNP Th1|th1|NN and|and|CC Th2|th2|NN cell|cell|NN involvement|involvement|NN in|in|IN immune|immune|JJ response|response|NN to|to|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN porins|porin|NNS .|.|. 
Immunology|Immunology|NNP .|.|. 
1998|1998|CD ;|;|: 94|94|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 5|5|CD --|--|: 13|13|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9708180|9708180|CD ]|]|-RRB- 13|13|CD .|.|. 
Gately|gately|RB MK|MK|NNP ,|,|, Renzetti|renzetti|NN LM|lm|NN ,|,|, Magram|Magram|NNP J|J|NNP ,|,|, Stern|Stern|NNP AS|AS|NNP ,|,|, Adorini|Adorini|NNP L|L|NNP ,|,|, Gubler|Gubler|NNP U|U|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
The|the|DT interleukin|interleukin|NN -|-|HYPH 12|12|CD /|/|HYPH interleukin|interleukin|NN -12-receptor|-12-receptor|NN system|system|NN :|:|: role|role|NN in|in|IN normal|normal|JJ and|and|CC pathologic|pathologic|JJ immune|immune|JJ responses|response|NNS .|.|. 
Annu|Annu|NNP Rev|Rev|NNP Immunol|Immunol|NNP .|.|. 
1998|1998|CD ;|;|: 16:495|16:495|CD --|--|: 521|521|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9597139|9597139|CD ]|]|-RRB- 14|14|CD .|.|. 
Aliprantis|Aliprantis|NNP AO|AO|NNP ,|,|, Yang|Yang|NNP RB|RB|NNP ,|,|, Mark|Mark|NNP MR|MR|NNP ,|,|, Suggett|Suggett|NNP S|S|NNP ,|,|, Devaux|Devaux|NNP B|B|NNP ,|,|, Radolf|Radolf|NNP JD|JD|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Cell|cell|NN activation|activation|NN and|and|CC apoptosis|apoptosis|NN by|by|IN bacterial|bacterial|JJ lipoproteins|lipoprotein|NNS through|through|IN toll|toll|NN -|-|HYPH like|like|JJ receptor|receptor|NN -|-|HYPH 2|2|CD .|.|. 
Science|Science|NNP .|.|. 
1999|1999|CD ;|;|: 285|285|CD (|(|-LRB- 5428|5428|CD )|)|-RRB- :|:|: 736|736|CD --|--|: 739|739|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10426996|10426996|CD ]|]|-RRB- 15|15|CD .|.|. 
Brightbill|Brightbill|NNP HD|HD|NNP ,|,|, Libraty|Libraty|NNP DH|DH|NNP ,|,|, Krutzik|Krutzik|NNP SR|SR|NNP ,|,|, Yang|Yang|NNP RB|RB|NNP ,|,|, Belisle|Belisle|NNP JT|JT|NNP ,|,|, Bleharski|Bleharski|NNP JR|JR|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Host|host|NN defense|defense|NN mechanisms|mechanism|NNS triggered|trigger|VBN by|by|IN microbial|microbial|JJ lipoproteins|lipoprotein|NNS through|through|IN toll|toll|NN -|-|HYPH like|like|JJ receptors|receptor|NNS .|.|. 
Science|Science|NNP .|.|. 
1999|1999|CD ;|;|: 285|285|CD (|(|-LRB- 5428|5428|CD )|)|-RRB- :|:|: 732|732|CD --|--|: 736|736|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10426995|10426995|CD ]|]|-RRB- 16|16|CD .|.|. 
Reubi|Reubi|NNP JC|JC|NNP ,|,|, Kvols|Kvols|NNP LK|LK|NNP ,|,|, Waser|Waser|NNP B|B|NNP ,|,|, Nagorney|Nagorney|NNP DM|DM|NNP ,|,|, Heitz|Heitz|NNP PU|PU|NNP ,|,|, Charboneau|Charboneau|NNP JW|JW|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Detection|detection|NN of|of|IN somatostatin|somatostatin|NN receptors|receptor|NNS in|in|IN surgical|surgical|JJ and|and|CC percutaneous|percutaneous|JJ needle|needle|NN biopsy|biopsy|NN samples|sample|NNS of|of|IN carcinoids|carcinoid|NNS and|and|CC islet|islet|NN cell|cell|NN carcinomas|carcinoma|NNS .|.|. 
Cancer|Cancer|NNP Res|Res|NNP .|.|. 
1990|1990|CD ;|;|: 50|50|CD (|(|-LRB- 18|18|CD )|)|-RRB- :|:|: 5969|5969|CD --|--|: 5977|5977|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2168286|2168286|CD ]|]|-RRB- 17|17|CD .|.|. 
Liu|Liu|NNP T|T|NNP ,|,|, Konig|Konig|NNP R|R|NNP ,|,|, Sha|Sha|NNP J|J|NNP ,|,|, Agar|Agar|NNP SL|SL|NNP ,|,|, Tseng|Tseng|NNP CT|CT|NNP ,|,|, Klimpel|Klimpel|NNP GR|GR|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Immunological|immunological|JJ responses|response|NNS against|against|IN Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NNP Typhimurium|Typhimurium|NNP Braun|Braun|NNP lipoprotein|lipoprotein|NN and|and|CC lipid|lipid|NN A|a|NN mutant|mutant|NN strains|strain|NNS in|in|IN SwissWebster|SwissWebster|NNP mice|mouse|NNS :|:|: potential|potential|JJ use|use|NN as|as|RB live|live|RB -|-|HYPH attenuated|attenuate|VBN vaccines|vaccine|NNS .|.|. 
Microb|Microb|NNP Pathog|Pathog|NNP .|.|. 
2008|2008|CD ;|;|: 44|44|CD (|(|-LRB- 3|3|CD )|)|-RRB- :|:|: 224|224|CD --|--|: 237|237|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17997275|17997275|CD ]|]|-RRB- 18|18|CD .|.|. 
Bluestone|Bluestone|NNP JA|JA|NNP ,|,|, Tang|Tang|NNP Q|Q|NNP .|.|. 
How|how|WRB do|do|VBP CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM regulatory|regulatory|JJ T|t|NN cells|cell|NNS control|control|VBP autoimmunity|autoimmunity|NN ?|?|. 
Curr|Curr|NNP Opin|Opin|NNP Immunol|Immunol|NNP .|.|. 
2005|2005|CD ;|;|: 17|17|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 638|638|CD --|--|: 642|642|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 16209918|16209918|CD ]|]|-RRB- 19|19|CD .|.|. 
Itoh|Itoh|NNP M|M|NNP ,|,|, Takahashi|Takahashi|NNP T|T|NNP ,|,|, Sakaguchi|Sakaguchi|NNP N|N|NNP ,|,|, Kuniyasu|Kuniyasu|NNP Y|Y|NNP ,|,|, Shimizu|Shimizu|NNP J|J|NNP ,|,|, Otsuka|Otsuka|NNP F|F|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Thymus|thymus|NN and|and|CC autoimmunity|autoimmunity|NN :|:|: production|production|NN of|of|IN CD25|cd25|NN +|+|SYM CD4|cd4|NN +|+|SYM naturally|naturally|RB anergic|anergic|JJ and|and|CC suppressive|suppressive|JJ T|t|NN cells|cell|NNS as|as|IN a|a|DT key|key|JJ function|function|NN of|of|IN the|the|DT thymus|thymus|NN in|in|IN maintaining|maintain|VBG immunologic|immunologic|JJ self|self|NN -|-|HYPH tolerance|tolerance|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1999|1999|CD ;|;|: 162|162|CD (|(|-LRB- 9|9|CD )|)|-RRB- :|:|: 5317|5317|CD --|--|: 5326|5326|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10228007|10228007|CD ]|]|-RRB- 20|20|CD .|.|. 
Nomura|Nomura|NNP T|T|NNP ,|,|, Sakaguchi|Sakaguchi|NNP S.|S.|NNP Naturally|naturally|RB arising|arise|VBG CD25|cd25|NN +|+|SYM CD4|cd4|NN +|+|SYM regulatory|regulatory|JJ T|t|NN cells|cell|NNS in|in|IN tumor|tumor|NN immunity|immunity|NN .|.|. 
Curr|Curr|NNP Top|Top|NNP Microbiol|Microbiol|NNP Immunol|Immunol|NNP .|.|. 
2005|2005|CD ;|;|: 293:287|293:287|CD --|--|: 302|302|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 15981485|15981485|CD ]|]|-RRB- 21|21|CD .|.|. 
Zou|Zou|NNP W.|W.|NNP Regulatory|Regulatory|NNP T|T|NNP cells|cell|NNS ,|,|, tumour|tumour|NN immunity|immunity|NN and|and|CC immunotherapy|immunotherapy|NN .|.|. 
Nat|nat|JJ Rev|Rev|NNP Immunol|Immunol|NNP .|.|. 
2006|2006|CD ;|;|: 6|6|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 295|295|CD --|--|: 307|307|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 16557261|16557261|CD ]|]|-RRB- 22|22|CD .|.|. 
Shimizu|Shimizu|NNP J|J|NNP ,|,|, Yamazaki|Yamazaki|NNP S|S|NNP ,|,|, Sakaguchi|Sakaguchi|NNP S.|S.|NNP Induction|induction|NN of|of|IN tumor|tumor|NN immunity|immunity|NN by|by|IN removing|remove|VBG CD25|cd25|NN +|+|SYM CD4|cd4|NN +|+|SYM T|t|NN cells|cell|NNS :|:|: a|a|DT common|common|JJ basis|basis|NN between|between|IN tumor|tumor|NN immunity|immunity|NN and|and|CC autoimmunity|autoimmunity|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1999|1999|CD ;|;|: 163|163|CD (|(|-LRB- 10|10|CD )|)|-RRB- :|:|: 5211|5211|CD --|--|: 5218|5218|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10553041|10553041|CD ]|]|-RRB- 23|23|CD .|.|. 
Turk|Turk|NNP MJ|MJ|NNP ,|,|, Guevara|Guevara|NNP -|-|HYPH Patino|Patino|NNP JA|JA|NNP ,|,|, Rizzuto|Rizzuto|NNP GA|GA|NNP ,|,|, Engelhorn|Engelhorn|NNP ME|ME|NNP ,|,|, Sakaguchi|Sakaguchi|NNP S|S|NNP ,|,|, Houghton|Houghton|NNP AN|a|DT .|.|. 
Concomitant|concomitant|JJ tumor|tumor|NN immunity|immunity|NN to|to|IN a|a|DT poorly|poorly|RB immunogenic|immunogenic|JJ melanoma|melanoma|NN is|be|VBZ prevented|prevent|VBN by|by|IN regulatory|regulatory|JJ T|t|NN cells|cell|NNS .|.|. 
J|j|NN Exp|exp|NN Med|Med|NNP .|.|. 
2004|2004|CD ;|;|: 200|200|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 771|771|CD --|--|: 782|782|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 15381730|15381730|CD ]|]|-RRB- 24|24|CD .|.|. 
Sutmuller|sutmuller|NN RP|rp|NN ,|,|, van|van|NN Duivenvoorde|duivenvoorde|NN LM|lm|NN ,|,|, van|van|NNP Elsas|Elsas|NNP A|A|NNP ,|,|, Schumacher|Schumacher|NNP TN|TN|NNP ,|,|, Wildenberg|Wildenberg|NNP ME|ME|NNP ,|,|, Allison|Allison|NNP JP|JP|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Synergism|synergism|NN of|of|IN cytotoxic|cytotoxic|JJ T|t|NN lymphocyte|lymphocyte|NN -|-|HYPH associated|associate|VBN antigen|antigen|NN 4|4|CD blockade|blockade|NN and|and|CC depletion|depletion|NN of|of|IN CD25|cd25|NN (|(|-LRB- +|+|SYM )|)|-RRB- regulatory|regulatory|JJ T|t|NN cells|cell|NNS in|in|IN antitumor|antitumor|NN therapy|therapy|NN reveals|reveal|VBZ alternative|alternative|JJ pathways|pathway|NNS for|for|IN suppression|suppression|NN of|of|IN autoreactive|autoreactive|JJ cytotoxic|cytotoxic|JJ T|t|NN lymphocyte|lymphocyte|NN responses|response|NNS .|.|. 
J|j|NN Exp|exp|NN Med|Med|NNP .|.|. 
2001|2001|CD ;|;|: 194|194|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 823|823|CD --|--|: 832|832|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11560997|11560997|CD ]|]|-RRB- 25|25|CD .|.|. 
Bajorath|Bajorath|NNP J.|J.|NNP Understanding|understand|VBG the|the|DT structural|structural|JJ basis|basis|NN of|of|IN T|t|NN -|-|HYPH cell|cell|NN costimulation|costimulation|NN .|.|. 
J|J|NNP Mol|Mol|NNP Graph|Graph|NNP Model|Model|NNP .|.|. 
2000|2000|CD ;|;|: 18|18|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 176|176|CD --|--|: 179|179|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10994522|10994522|CD ]|]|-RRB- 26|26|CD .|.|. 
Lesley|Lesley|NNP J|J|NNP ,|,|, Kincade|Kincade|NNP PW|PW|NNP ,|,|, Hyman|Hyman|NNP R.|R.|NNP Antibody|antibody|NN -|-|HYPH induced|induce|VBN activation|activation|NN of|of|IN the|the|DT hyaluronan|hyaluronan|NN receptor|receptor|NN function|function|NN of|of|IN CD44|cd44|NN requires|require|VBZ multivalent|multivalent|JJ binding|binding|NN by|by|IN antibody|antibody|NN .|.|. 
Eur|Eur|NNP J|J|NNP Immunol|Immunol|NNP .|.|. 
1993|1993|CD ;|;|: 23|23|CD (|(|-LRB- 8|8|CD )|)|-RRB- :|:|: 1902|1902|CD --|--|: 1909|1909|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 7688309|7688309|CD ]|]|-RRB- 27|27|CD .|.|. 
Martin|Martin|NNP TA|TA|NNP ,|,|, Harrison|Harrison|NNP G|G|NNP ,|,|, Mansel|Mansel|NNP RE|re|NN ,|,|, Jiang|Jiang|NNP WG|WG|NNP .|.|. 
The|the|DT role|role|NN of|of|IN the|the|DT CD44|cd44|NN /|/|HYPH ezrin|ezrin|NN complex|complex|NN in|in|IN cancer|cancer|NN metastasis|metastasis|NN .|.|. 
Crit|Crit|NNP Rev|Rev|NNP Oncol|Oncol|NNP Hematol|Hematol|NNP .|.|. 
2003|2003|CD ;|;|: 46|46|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 165|165|CD --|--|: 186|186|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12711360|12711360|CD ]|]|-RRB- 28|28|CD .|.|. 
Ponta|Ponta|NNP H|H|NNP ,|,|, Sherman|Sherman|NNP L|L|NNP ,|,|, Herrlich|Herrlich|NNP PA.|PA.|NNP .|.|. 
CD44|cd44|NN :|:|: from|from|IN adhesion|adhesion|NN molecules|molecule|NNS to|to|IN signalling|signalling|NN regulators|regulator|NNS .|.|. 
Nat|nat|JJ Rev|Rev|NNP Mol|Mol|NNP Cell|Cell|NNP Biol|Biol|NNP .|.|. 
2003|2003|CD ;|;|: 4|4|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 33|33|CD --|--|: 45|45|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12511867|12511867|CD ]|]|-RRB- 29|29|CD .|.|. 
Stamenkovic|Stamenkovic|NNP I|I|PRP ,|,|, Amiot|Amiot|NNP M|M|NNP ,|,|, Pesando|Pesando|NNP JM|JM|NNP ,|,|, Seed|seed|NN B|b|NN .|.|. 
A|a|DT lymphocyte|lymphocyte|NN molecule|molecule|NN implicated|implicate|VBN in|in|IN lymph|lymph|NN node|node|NN homing|homing|NN is|be|VBZ a|a|DT member|member|NN of|of|IN the|the|DT cartilage|cartilage|NN link|link|NN protein|protein|NN family|family|NN .|.|. 
Cell|cell|NN .|.|. 
1989|1989|CD ;|;|: 56|56|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 1057|1057|CD --|--|: 1062|1062|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2466575|2466575|CD ]|]|-RRB- 30|30|CD .|.|. 
Berg|Berg|NNP EL|EL|NNP ,|,|, Goldstein|Goldstein|NNP LA|LA|NNP ,|,|, Jutila|Jutila|NNP MA|MA|NNP ,|,|, Nakache|Nakache|NNP M|M|NNP ,|,|, Picker|Picker|NNP LJ|LJ|NNP ,|,|, Streeter|Streeter|NNP PR|PR|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Homing|home|VBG receptors|receptor|NNS and|and|CC vascular|vascular|JJ addressins|addressin|NNS :|:|: cell|cell|NN adhesion|adhesion|NN molecules|molecule|NNS that|that|WDT direct|direct|JJ lymphocyte|lymphocyte|NN traffic|traffic|NN .|.|. 
Immunol|Immunol|NNP Rev.|Rev.|NNP 1989|1989|CD ;|;|: 108:5|108:5|CD --|--|: 18|18|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2670744|2670744|CD ]|]|-RRB- 31|31|CD .|.|. 
Shimizu|Shimizu|NNP Y|Y|NNP ,|,|, Van|Van|NNP Seventer|Seventer|NNP GA|GA|NNP ,|,|, Siraganian|Siraganian|NNP R|R|NNP ,|,|, Wahl|Wahl|NNP L|L|NNP ,|,|, Shaw|Shaw|NNP S.|S.|NNP Dual|Dual|NNP role|role|NN of|of|IN the|the|DT CD44|cd44|NN molecule|molecule|NN in|in|IN T|t|NN cell|cell|NN adhesion|adhesion|NN and|and|CC activation|activation|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1989|1989|CD ;|;|: 143|143|CD (|(|-LRB- 8|8|CD )|)|-RRB- :|:|: 2457|2457|CD --|--|: 2463|2463|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 2677141|2677141|CD ]|]|-RRB- 32|32|CD .|.|. 
Denning|den|VBG SM|SM|NNP ,|,|, Le|Le|NNP PT|pt|NN ,|,|, Singer|singer|NN KH|kh|NN ,|,|, Haynes|Haynes|NNP BF|bf|NN .|.|. 
Antibodies|antibody|NNS against|against|IN the|the|DT CD44|cd44|NN p80|p80|NN ,|,|, lymphocyte|lymphocyte|NN homing|homing|NN receptor|receptor|NN molecule|molecule|NN augment|augment|VB human|human|JJ peripheral|peripheral|JJ blood|blood|NN T|t|NN cell|cell|NN activation|activation|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1990|1990|CD ;|;|: 144|144|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 7|7|CD --|--|: 15|15|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 1967267|1967267|CD ]|]|-RRB- 33|33|CD .|.|. 
Rafi|Rafi|NNP A|A|NNP ,|,|, Nagarkatti|Nagarkatti|NNP M|M|NNP ,|,|, Nagarkatti|Nagarkatti|NNP PS|PS|NNP .|.|. 
Hyaluronate|hyaluronate|NN -|-|HYPH CD44|cd44|NN interactions|interaction|NNS can|can|MD induce|induce|VB murine|murine|JJ B|b|NN -|-|HYPH cell|cell|NN activation|activation|NN .|.|. 
Blood|blood|NN .|.|. 
1997|1997|CD ;|;|: 89|89|CD (|(|-LRB- 8|8|CD )|)|-RRB- :|:|: 2901|2901|CD --|--|: 2908|2908|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9108410|9108410|CD ]|]|-RRB- 34|34|CD .|.|. 
Aziz|Aziz|NNP KA|ka|NN ,|,|, Till|till|IN KJ|KJ|NNP ,|,|, Zuzel|Zuzel|NNP M|M|NNP ,|,|, Cawley|Cawley|NNP JC|JC|NNP .|.|. 
Involvement|involvement|NN of|of|IN CD44|cd44|NN -|-|HYPH hyaluronan|hyaluronan|NN interaction|interaction|NN in|in|IN malignant|malignant|JJ cell|cell|NN homing|homing|NN and|and|CC fibronectin|fibronectin|NN synthesis|synthesis|NN in|in|IN hairy|hairy|JJ cell|cell|NN leukemia|leukemia|NN .|.|. 
Blood|blood|NN .|.|. 
2000|2000|CD ;|;|: 96|96|CD (|(|-LRB- 9|9|CD )|)|-RRB- :|:|: 3161|3161|CD --|--|: 3167|3167|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11049998|11049998|CD ]|]|-RRB- 35|35|CD .|.|. 
Mummert|Mummert|NNP ME|ME|NNP ,|,|, Mummert|Mummert|NNP DI|DI|NNP ,|,|, Ellinger|Ellinger|NNP L|L|NNP ,|,|, Takashima|Takashima|NNP A.|A.|NNP Functional|Functional|NNP roles|role|NNS of|of|IN hyaluronan|hyaluronan|NN in|in|IN B16|b16|NN -|-|HYPH F10|f10|NN melanoma|melanoma|NN growth|growth|NN and|and|CC experimental|experimental|JJ metastasis|metastasis|NN in|in|IN mice|mouse|NNS .|.|. 
Mol|Mol|NNP Cancer|Cancer|NNP Ther|Ther|NNP .|.|. 
2003|2003|CD ;|;|: 2|2|CD (|(|-LRB- 3|3|CD )|)|-RRB- :|:|: 295|295|CD --|--|: 300|300|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12657724|12657724|CD ]|]|-RRB- 36|36|CD .|.|. 
Huang|Huang|NNP S|S|NNP ,|,|, Xie|Xie|NNP K|K|NNP ,|,|, Bucana|Bucana|NNP CD|CD|NNP ,|,|, Ullrich|Ullrich|NNP SE|SE|NNP ,|,|, Bar|Bar|NNP -|-|HYPH Eli|Eli|NNP M.|M.|NNP Interleukin|Interleukin|NNP 10|10|CD suppresses|suppress|VBZ tumor|tumor|NN growth|growth|NN and|and|CC metastasis|metastasis|NN of|of|IN human|human|JJ melanoma|melanoma|NN cells|cell|NNS :|:|: potential|potential|JJ inhibition|inhibition|NN of|of|IN angiogenesis|angiogenesis|NN .|.|. 
Clin|Clin|NNP Cancer|Cancer|NNP Res|Res|NNP .|.|. 
1996|1996|CD ;|;|: 2|2|CD (|(|-LRB- 12|12|CD )|)|-RRB- :|:|: 1969|1969|CD --|--|: 1979|1979|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9816156|9816156|CD ]|]|-RRB- 37|37|CD .|.|. 
Stearns|Stearns|NNP ME|ME|NNP ,|,|, Wang|Wang|NNP M.|M.|NNP Antimestatic|Antimestatic|NNP and|and|CC antitumor|antitumor|JJ activities|activity|NNS of|of|IN interleukin|interleukin|NN 10|10|CD in|in|IN transfected|transfect|VBN human|human|JJ prostate|prostate|NN PC|pc|NN -|-|HYPH 3|3|CD ML|ML|NNP clones|clone|NNS :|:|: Orthotopic|orthotopic|JJ growth|growth|NN in|in|IN severe|severe|JJ combined|combine|VBN immunodeficient|immunodeficient|NN mice|mouse|NNS .|.|. 
Clin|Clin|NNP Cancer|Cancer|NNP Res|Res|NNP .|.|. 
1998|1998|CD ;|;|: 4|4|CD (|(|-LRB- 9|9|CD )|)|-RRB- :|:|: 2257|2257|CD --|--|: 2263|2263|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 9748147|9748147|CD ]|]|-RRB- 38|38|CD .|.|. 
Faupel|Faupel|NNP -|-|HYPH Badger|Badger|NNP JM|JM|NNP ,|,|, Kidd|Kidd|NNP LC|lc|NN ,|,|, Albanes|Albanes|NNP D|D|NNP ,|,|, Virtamo|Virtamo|NNP J|J|NNP ,|,|, Woodson|Woodson|NNP K|K|NNP ,|,|, Tangrea|Tangrea|NNP JA|JA|NNP .|.|. 
Association|Association|NNP of|of|IN IL|IL|NNP -|-|HYPH 10|10|CD polymorphisms|polymorphism|NNS with|with|IN prostate|prostate|NN cancer|cancer|NN risk|risk|NN and|and|CC grade|grade|NN of|of|IN disease|disease|NN .|.|. 
Cancer|Cancer|NNP Causes|cause|VBZ Control|control|NN .|.|. 
2008|2008|CD ;|;|: 19|19|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 119|119|CD --|--|: 124|124|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17999153|17999153|CD ]|]|-RRB- 39|39|CD .|.|. 
Lin|Lin|NNP W|W|NNP ,|,|, Haribhai|Haribhai|NNP D|D|NNP ,|,|, Relland|Relland|NNP LM|lm|NN ,|,|, Truong|Truong|NNP N|N|NNP ,|,|, Carlson|Carlson|NNP MR|MR|NNP ,|,|, Williams|Williams|NNP CB|CB|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Regulatory|Regulatory|NNP T|T|NNP cell|cell|NN development|development|NN in|in|IN the|the|DT absence|absence|NN of|of|IN functional|functional|JJ Foxp3|foxp3|NN .|.|. 
Nat|nat|JJ Immunol|Immunol|NNP .|.|. 
2007|2007|CD ;|;|: 8|8|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 359|359|CD --|--|: 368|368|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17273171|17273171|CD ]|]|-RRB- 40|40|CD .|.|. 
Toso|Toso|NNP JF|JF|NNP ,|,|, Gill|Gill|NNP VJ|VJ|NNP ,|,|, Hwu|Hwu|NNP P|P|NNP ,|,|, Marincola|Marincola|NNP FM|FM|NNP ,|,|, Restifo|Restifo|NNP NP|NP|NNP ,|,|, Schwartzentruber|Schwartzentruber|NNP DJ|DJ|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Phase|phase|NN I|I|PRP study|study|VBP of|of|IN the|the|DT intravenous|intravenous|JJ administration|administration|NN of|of|IN attenuated|attenuate|VBN Salmonella|salmonella|NN typhimurium|typhimurium|NN to|to|IN patients|patient|NNS with|with|IN metastatic|metastatic|JJ melanoma|melanoma|NN .|.|. 
J|j|NN Clin|clin|NN Oncol|oncol|NN .|.|. 
2002|2002|CD ;|;|: 20|20|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 142|142|CD --|--|: 152|152|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11773163|11773163|CD ]|]|-RRB- 41|41|CD .|.|. 
Sakaguchi|Sakaguchi|NNP S|S|NNP ,|,|, Sakaguchi|Sakaguchi|NNP N|N|NNP ,|,|, Shimizu|Shimizu|NNP J|J|NNP ,|,|, Yamazaki|Yamazaki|NNP S|S|NNP ,|,|, Sakihama|Sakihama|NNP T|T|NNP ,|,|, Itoh|Itoh|NNP M|M|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Immunologic|immunologic|JJ tolerance|tolerance|NN maintained|maintain|VBN by|by|IN CD25|cd25|NN +|+|SYM CD4|cd4|NN +|+|SYM regulatory|regulatory|JJ T|t|NN cells|cell|NNS :|:|: their|they|PRP$ common|common|JJ role|role|NN in|in|IN controlling|control|VBG autoimmunity|autoimmunity|NN ,|,|, tumor|tumor|NN immunity|immunity|NN ,|,|, and|and|CC transplantation|transplantation|NN tolerance|tolerance|NN .|.|. 
Immunol|Immunol|NNP Rev.|Rev.|NNP 2001|2001|CD ;|;|, 182:18|182:18|CD --|--|: 32|32|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11722621|11722621|CD ]|]|-RRB- 42|42|CD .|.|. 
Shevach|Shevach|NNP EM|EM|NNP .|.|. 
CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM suppressor|suppressor|NN T|t|NN cells|cell|NNS :|:|: more|more|JJR questions|question|NNS than|than|IN answers|answer|NNS .|.|. 
Nat|nat|JJ Rev|Rev|NNP Immunol|Immunol|NNP .|.|. 
2002|2002|CD ;|;|: 2|2|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 389|389|CD --|--|: 400|400|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12093005|12093005|CD ]|]|-RRB- 43|43|CD .|.|. 
Yu|Yu|NNP P|P|NNP ,|,|, Lee|Lee|NNP Y|Y|NNP ,|,|, Liu|Liu|NNP W|W|NNP ,|,|, Krausz|Krausz|NNP T|T|NNP ,|,|, Chong|Chong|NNP A|A|NNP ,|,|, Schreiber|Schreiber|NNP H|H|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Intratumor|Intratumor|NNP depletion|depletion|NN of|of|IN CD4|cd4|NN +|+|SYM cells|cell|NNS unmasks|unmask|VBZ tumor|tumor|NN immunogenicity|immunogenicity|NN leading|lead|VBG to|to|IN the|the|DT rejection|rejection|NN of|of|IN late|late|JJ -|-|HYPH stage|stage|NN tumors|tumor|NNS .|.|. 
J|j|NN Exp|exp|NN Med|Med|NNP .|.|. 
2005|2005|CD ;|;|: 201|201|CD (|(|-LRB- 5|5|CD )|)|-RRB- :|:|: 779|779|CD --|--|: 791|791|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 15753211|15753211|CD ]|]|-RRB- 44|44|CD .|.|. 
Zhou|Zhou|NNP G|G|NNP ,|,|, Drake|Drake|NNP CG|CG|NNP ,|,|, Levitsky|Levitsky|NNP HI|HI|NNP .|.|. 
Amplification|amplification|NN of|of|IN tumor|tumor|NN -|-|HYPH specific|specific|JJ regulatory|regulatory|JJ T|t|NN cells|cell|NNS following|follow|VBG therapeutic|therapeutic|JJ cancer|cancer|NN vaccines|vaccine|NNS .|.|. 
Blood|blood|NN .|.|. 
2006|2006|CD ;|;|: 107|107|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 628|628|CD --|--|: 636|636|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 16179369|16179369|CD ]|]|-RRB- 45|45|CD .|.|. 
Duan|Duan|NNP W|W|NNP ,|,|, So|so|RB T|t|NN ,|,|, Croft|Croft|NNP M.|M.|NNP Antagonism|antagonism|NN of|of|IN airway|airway|NN tolerance|tolerance|NN by|by|IN endotoxin|endotoxin|NN /|/|HYPH lipopolysaccharide|lipopolysaccharide|NN through|through|IN promoting|promote|VBG OX40L|ox40l|NN and|and|CC suppressing|suppress|VBG antigen|antigen|NN -|-|HYPH specific|specific|JJ Foxp3|foxp3|NN +|+|SYM T|t|NN regulatory|regulatory|JJ cells|cell|NNS .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
2008|2008|CD ;|;|: 181|181|CD (|(|-LRB- 12|12|CD )|)|-RRB- :|:|: 8650|8650|CD --|--|: 8659|8659|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 19050285|19050285|CD ]|]|-RRB- 46|46|CD .|.|. 
Lewkowicz|Lewkowicz|NNP P|P|NNP ,|,|, Lewkowicz|Lewkowicz|NNP N|N|NNP ,|,|, Sasiak|Sasiak|NNP A|A|NNP ,|,|, Tchorzewski|Tchorzewski|NNP H.|H.|NNP Lipopolysaccharide|Lipopolysaccharide|NNP -|-|HYPH activated|activate|VBN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM T|t|NN regulatory|regulatory|JJ cells|cell|NNS inhibit|inhibit|VBP neutrophil|neutrophil|NN function|function|NN and|and|CC promote|promote|VB their|they|PRP$ apoptosis|apoptosis|NN and|and|CC death|death|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
2006|2006|CD ;|;|: 177|177|CD (|(|-LRB- 10|10|CD )|)|-RRB- :|:|: 7155|7155|CD --|--|: 7163|7163|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17082633|17082633|CD ]|]|-RRB- 47|47|CD .|.|. 
Clayton|Clayton|NNP A|A|NNP ,|,|, Mitchell|Mitchell|NNP JP|JP|NNP ,|,|, Court|Court|NNP J|j|NN ,|,|, Mason|Mason|NNP MD|MD|NNP ,|,|, Tabi|Tabi|NNP Z.|Z.|NNP Human|Human|NNP tumor|tumor|NN -|-|HYPH derived|derive|VBN exosomes|exosome|NNS selectively|selectively|RB impair|impair|VBP lymphocyte|lymphocyte|NN responses|response|NNS to|to|IN interleukin|interleukin|NN -|-|HYPH 2|2|CD .|.|. 
Cancer|Cancer|NNP Res|Res|NNP .|.|. 
2007|2007|CD ;|;|: 67|67|CD (|(|-LRB- 15|15|CD )|)|-RRB- :|:|: 7458|7458|CD --|--|: 7466|7466|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17671216|17671216|CD ]|]|-RRB- 48|48|CD .|.|. 
Aggarwal|Aggarwal|NNP A|A|NNP ,|,|, Kumar|Kumar|NNP S|S|NNP ,|,|, Jaffe|Jaffe|NNP R|R|NNP ,|,|, Hone|Hone|NNP D|D|NNP ,|,|, Gross|Gross|NNP M|M|NNP ,|,|, Sadoff|Sadoff|NNP J.|J.|NNP Oral|oral|JJ Salmonella|salmonella|NN :|:|: malaria|malaria|NN circumsporozoite|circumsporozoite|NN recombinants|recombinant|NNS induce|induce|VBP specific|specific|JJ CD8|cd8|NN +|+|SYM cytotoxic|cytotoxic|JJ T|t|NN cells|cell|NNS .|.|. 
J|j|NN Exp|exp|NN Med|Med|NNP .|.|. 
1990|1990|CD ;|;|: 172|172|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 1083|1083|CD --|--|: 1090|1090|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 1698908|1698908|CD ]|]|-RRB- 49|49|CD .|.|. 
Schafer|Schafer|NNP R|R|NNP ,|,|, Eisenstein|Eisenstein|NNP TK|TK|NNP .|.|. 
Natural|natural|JJ killer|killer|NN cells|cell|NNS mediate|mediate|VBP protection|protection|NN induced|induce|VBN by|by|IN a|a|DT Salmonella|salmonella|NN aroA|aroa|NN mutant|mutant|NN .|.|. 
Infect|infect|VB Immun|Immun|NNP .|.|. 
1992|1992|CD ;|;|: 60|60|CD (|(|-LRB- 3|3|CD )|)|-RRB- :|:|: 791|791|CD --|--|: 797|797|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 1541553|1541553|CD ]|]|-RRB- 50|50|CD .|.|. 
Tam|Tam|NNP MA|MA|NNP ,|,|, Rydstrom|Rydstrom|NNP A|A|NNP ,|,|, Sundquist|Sundquist|NNP M|M|NNP ,|,|, Wick|Wick|NNP MJ|MJ|NNP .|.|. 
Early|early|JJ cellular|cellular|JJ responses|response|NNS to|to|IN Salmonella|salmonella|NN infection|infection|NN :|:|: dendritic|dendritic|JJ cells|cell|NNS ,|,|, monocytes|monocyte|NNS ,|,|, and|and|CC more|more|RBR .|.|. 
Immunol|Immunol|NNP Rev.|Rev.|NNP 2008|2008|CD ;|;|: 225|225|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 140|140|CD --|--|: 162|162|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 18837781|18837781|CD ]|]|-RRB- 51|51|CD .|.|. 
Yrlid|Yrlid|NNP U|U|NNP ,|,|, Svensson|Svensson|NNP M|M|NNP ,|,|, Hakansson|Hakansson|NNP A|A|NNP ,|,|, Chambers|Chambers|NNP BJ|BJ|NNP ,|,|, Ljunggren|Ljunggren|NNP HG|hg|NN ,|,|, Wick|Wick|NNP MJ|MJ|NNP .|.|. 
In|in|FW vivo|vivo|FW activation|activation|NN of|of|IN dendritic|dendritic|JJ cells|cell|NNS and|and|CC T|t|NN cells|cell|NNS during|during|IN Salmonella|salmonella|NN enterica|enterica|NN serovar|serovar|NN Typhimurium|typhimurium|NN infection|infection|NN .|.|. 
Infect|infect|VB Immun|Immun|NNP .|.|. 
2001|2001|CD ;|;|: 69|69|CD (|(|-LRB- 9|9|CD )|)|-RRB- :|:|: 5726|5726|CD --|--|: 5735|5735|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11500449|11500449|CD ]|]|-RRB- 52|52|CD .|.|. 
Rankin|Rankin|NNP EB|EB|NNP ,|,|, Yu|Yu|NNP D|D|NNP ,|,|, Jiang|Jiang|NNP J|J|NNP ,|,|, Shen|Shen|NNP H|H|NNP ,|,|, Pearce|Pearce|NNP EJ|EJ|NNP ,|,|, Goldschmidt|Goldschmidt|NNP MH|MH|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
An|a|DT essential|essential|JJ role|role|NN of|of|IN Th1|th1|NN responses|response|NNS and|and|CC interferon|interferon|NN gamma|gamma|NN in|in|IN infection|infection|NN -|-|HYPH mediated|mediate|VBN suppression|suppression|NN of|of|IN neoplastic|neoplastic|JJ growth|growth|NN .|.|. 
Cancer|Cancer|NNP Biol|Biol|NNP Ther|Ther|NNP .|.|. 
2003|2003|CD ;|;|: 2|2|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 687|687|CD --|--|: 693|693|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 14688478|14688478|CD ]|]|-RRB- 53|53|CD .|.|. 
Kirby|Kirby|NNP AC|AC|NNP ,|,|, Yrlid|Yrlid|NNP U|U|NNP ,|,|, Wick|Wick|NNP MJ|MJ|NNP .|.|. 
The|the|DT innate|innate|JJ immune|immune|JJ response|response|NN differs|differ|VBZ in|in|IN primary|primary|JJ and|and|CC secondary|secondary|JJ Salmonella|salmonella|NN infection|infection|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
2002|2002|CD ;|;|: 169|169|CD (|(|-LRB- 8|8|CD )|)|-RRB- :|:|: 4450|4450|CD --|--|: 4459|4459|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12370380|12370380|CD ]|]|-RRB- 54|54|CD .|.|. 
Muranski|Muranski|NNP P|P|NNP ,|,|, Restifo|Restifo|NNP NP|NP|NNP .|.|. 
Adoptive|adoptive|JJ immunotherapy|immunotherapy|NN of|of|IN cancer|cancer|NN using|use|VBG CD4|cd4|NN (|(|-LRB- +|+|SYM )|)|-RRB- T|t|NN cells|cell|NNS .|.|. 
Curr|Curr|NNP Opin|Opin|NNP Immunol|Immunol|NNP .|.|. 
2009|2009|CD 55|55|CD .|.|. 
Esendagli|Esendagli|NNP G|G|NNP ,|,|, Bruderek|Bruderek|NNP K|K|NNP ,|,|, Goldmann|Goldmann|NNP T|T|NNP ,|,|, Busche|Busche|NNP A|A|NNP ,|,|, Branscheid|Branscheid|NNP D|D|NNP ,|,|, Vollmer|Vollmer|NNP E|E|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Malignant|malignant|JJ and|and|CC non-malignant|non-malignant|JJ lung|lung|NN tissue|tissue|NN areas|area|NNS are|be|VBP differentially|differentially|RB populated|populate|VBN by|by|IN natural|natural|JJ killer|killer|NN cells|cell|NNS and|and|CC regulatory|regulatory|JJ T|t|NN cells|cell|NNS in|in|IN non-small|non-small|JJ cell|cell|NN lung|lung|NN cancer|cancer|NN .|.|. 
Lung|Lung|NNP Cancer|Cancer|NNP .|.|. 
2008|2008|CD ;|;|: 59|59|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 32|32|CD --|--|: 40|40|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17825949|17825949|CD ]|]|-RRB- 56|56|CD .|.|. 
Peng|Peng|NNP TS|TS|NNP ,|,|, Qiu|Qiu|NNP JS|JS|NNP ,|,|, Wu|Wu|NNP HX|HX|NNP ,|,|, Liang|Liang|NNP HZ|HZ|NNP ,|,|, Luo|Luo|NNP CQ|CQ|NNP .|.|. 
Expressions|expression|NNS of|of|IN CD44s|cd44|NNS ,|,|, MMP|mmp|NN -|-|HYPH 9|9|CD ,|,|, and|and|CC Ki|Ki|NNP -|-|HYPH 67|67|CD :|:|: possible|possible|JJ association|association|NN with|with|IN invasion|invasion|NN ,|,|, metastasis|metastasis|NN ,|,|, and|and|CC recurrence|recurrence|NN of|of|IN osteosarcoma|osteosarcoma|NN .|.|. 
Ai|Ai|NNP Zheng|Zheng|NNP .|.|. 
2002|2002|CD ;|;|: 21|21|CD (|(|-LRB- 7|7|CD )|)|-RRB- :|:|: 745|745|CD --|--|: 750|750|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12479099|12479099|CD ]|]|-RRB- 57|57|CD .|.|. 
Du|Du|NNP L|L|NNP ,|,|, Wang|Wang|NNP H|H|NNP ,|,|, He|he|PRP L|l|NN ,|,|, Zhang|Zhang|NNP J|J|NNP ,|,|, Ni|Ni|NNP B|B|NNP ,|,|, Wang|Wang|NNP X|X|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
CD44|cd44|NN is|be|VBZ of|of|IN functional|functional|JJ importance|importance|NN for|for|IN colorectal|colorectal|JJ cancer|cancer|NN stem|stem|NN cells|cell|NNS .|.|. 
Clin|Clin|NNP Cancer|Cancer|NNP Res|Res|NNP .|.|. 
2008|2008|CD ;|;|: 14|14|CD (|(|-LRB- 21|21|CD )|)|-RRB- :|:|: 6751|6751|CD --|--|: 6760|6760|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 18980968|18980968|CD ]|]|-RRB- 58|58|CD .|.|. 
Okamoto|Okamoto|NNP A|A|NNP ,|,|, Chikamatsu|Chikamatsu|NNP K|K|NNP ,|,|, Sakakura|Sakakura|NNP K|K|NNP ,|,|, Hatsushika|Hatsushika|NNP K|K|NNP ,|,|, Takahashi|Takahashi|NNP G|G|NNP ,|,|, Masuyama|Masuyama|NNP K.|K.|NNP Expansion|Expansion|NNP and|and|CC characterization|characterization|NN of|of|IN cancer|cancer|NN stem|stem|NN -|-|HYPH like|like|JJ cells|cell|NNS in|in|IN squamous|squamous|JJ cell|cell|NN carcinoma|carcinoma|NN of|of|IN the|the|DT head|head|NN and|and|CC neck|neck|NN .|.|. 
Oral|oral|JJ Oncol|oncol|NN .|.|. 
2008|2008|CD 59|59|CD .|.|. 
Al|Al|NNP -|-|HYPH Hajj|Hajj|NNP M|M|NNP ,|,|, Wicha|Wicha|NNP MS|MS|NNP ,|,|, Benito|Benito|NNP -|-|HYPH Hernandez|Hernandez|NNP A|A|NNP ,|,|, Morrison|Morrison|NNP SJ|SJ|NNP ,|,|, Clarke|Clarke|NNP MF|MF|NNP .|.|. 
Prospective|prospective|JJ identification|identification|NN of|of|IN tumorigenic|tumorigenic|JJ breast|breast|NN cancer|cancer|NN cells|cell|NNS .|.|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 2003|2003|CD ;|;|: 100|100|CD (|(|-LRB- 7|7|CD )|)|-RRB- :|:|: 3983|3983|CD --|--|: 3988|3988|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12629218|12629218|CD ]|]|-RRB- 60|60|CD .|.|. 
Dalerba|Dalerba|NNP P|P|NNP ,|,|, Dylla|Dylla|NNP SJ|SJ|NNP ,|,|, Park|Park|NNP IK|IK|NNP ,|,|, Liu|Liu|NNP R|R|NNP ,|,|, Wang|Wang|NNP X|X|NNP ,|,|, Cho|Cho|NNP RW|RW|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Phenotypic|phenotypic|JJ characterization|characterization|NN of|of|IN human|human|JJ colorectal|colorectal|JJ cancer|cancer|NN stem|stem|NN cells|cell|NNS .|.|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 2007|2007|CD ;|;|: 104|104|CD (|(|-LRB- 24|24|CD )|)|-RRB- :|:|: 10158|10158|CD --|--|: 10163|10163|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17548814|17548814|CD ]|]|-RRB- 61|61|CD .|.|. 
Inoue|Inoue|NNP T|T|NNP ,|,|, Yashiro|Yashiro|NNP M|M|NNP ,|,|, Nishimura|Nishimura|NNP S|S|NNP ,|,|, Maeda|Maeda|NNP K|K|NNP ,|,|, Sawada|Sawada|NNP T|T|NNP ,|,|, Ogawa|Ogawa|NNP Y|Y|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Matrix|matrix|NN metalloproteinase|metalloproteinase|NN -|-|HYPH 1|1|CD expression|expression|NN is|be|VBZ a|a|DT prognostic|prognostic|JJ factor|factor|NN for|for|IN patients|patient|NNS with|with|IN advanced|advanced|JJ gastric|gastric|JJ cancer|cancer|NN .|.|. 
Int|int|NN J|j|NN Mol|mol|NN Med|Med|NNP .|.|. 
1999|1999|CD ;|;|: 4|4|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 73|73|CD --|--|: 77|77|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10373641|10373641|CD ]|]|-RRB- 62|62|CD .|.|. 
Kleiner|kleiner|NN DE|de|NN ,|,|, Stetler|Stetler|NNP -|-|HYPH Stevenson|Stevenson|NNP WG|WG|NNP .|.|. 
Matrix|matrix|NN metalloproteinases|metalloproteinase|NNS and|and|CC metastasis|metastasis|NN .|.|. 
Cancer|Cancer|NNP Chemother|Chemother|NNP Pharmacol|Pharmacol|NNP .|.|. 
1999|1999|CD ;|;|: 43|43|CD (|(|-LRB- Suppl|suppl|NN )|)|-RRB- :|:|: S42|s42|NN --|--|: S51|s51|NN .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 10357558|10357558|CD ]|]|-RRB- 63|63|CD .|.|. 
Sheridan|Sheridan|NNP C|C|NNP ,|,|, Kishimoto|Kishimoto|NNP H|H|NNP ,|,|, Fuchs|Fuchs|NNP RK|RK|NNP ,|,|, Mehrotra|Mehrotra|NNP S|S|NNP ,|,|, Bhat|Bhat|NNP -|-|HYPH Nakshatri|Nakshatri|NNP P|p|NN ,|,|, Turner|Turner|NNP CH|CH|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
CD44|cd44|NN +|+|SYM /|/|HYPH CD24|cd24|NN -|-|HYPH breast|breast|NN cancer|cancer|NN cells|cell|NNS exhibit|exhibit|VBP enhanced|enhance|VBN invasive|invasive|JJ properties|property|NNS :|:|: an|a|DT early|early|JJ step|step|NN necessary|necessary|JJ for|for|IN metastasis|metastasis|NN .|.|. 
Breast|breast|NN Cancer|cancer|NN Res|re|NNS .|.|. 
2006|2006|CD ;|;|: 8|8|CD (|(|-LRB- 5|5|CD )|)|-RRB- :|:|: R59|r59|NN .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 17062128|17062128|CD ]|]|-RRB- 64|64|CD .|.|. 
Gee|gee|NN K|k|NN ,|,|, Kozlowski|Kozlowski|NNP M|M|NNP ,|,|, Kryworuchko|Kryworuchko|NNP M|M|NNP ,|,|, Diaz|Diaz|NNP -|-|HYPH Mitoma|Mitoma|NNP F|F|NNP ,|,|, Kumar|Kumar|NNP A.|A.|NNP Differential|Differential|NNP effect|effect|NN of|of|IN IL|il|NN -|-|HYPH 4|4|CD and|and|CC IL|il|NN -|-|HYPH 13|13|CD on|on|IN CD44|cd44|NN expression|expression|NN in|in|IN the|the|DT Burkitt|Burkitt|NNP 's|'s|POS lymphoma|lymphoma|NN B|b|NN cell|cell|NN line|line|NN BL30|bl30|NN /|/|HYPH B95|b95|NN -8|-8|NN and|and|CC in|in|IN Epstein|Epstein|NNP -|-|HYPH Barr|Barr|NNP virus|virus|NN (|(|-LRB- EBV|ebv|NN )|)|-RRB- transformed|transform|VBN human|human|JJ B|b|NN cells|cell|NNS :|:|: loss|loss|NN of|of|IN IL|il|NN -|-|HYPH 13|13|CD receptors|receptor|NNS on|on|IN Burkitt|Burkitt|NNP 's|'s|POS lymphoma|lymphoma|NN B|b|NN cells|cell|NNS .|.|. 
Cell|cell|NN Immunol|immunol|NN .|.|. 
2001|2001|CD ;|;|: 211|211|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 131|131|CD --|--|: 142|142|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11591117|11591117|CD ]|]|-RRB- 65|65|CD .|.|. 
Gee|gee|NN K|k|NN ,|,|, Kozlowski|Kozlowski|NNP M|M|NNP ,|,|, Kumar|Kumar|NNP A.|A.|NNP Tumor|Tumor|NNP necrosis|necrosis|NN factor|factor|NN -|-|HYPH alpha|alpha|NN induces|induce|VBZ functionally|functionally|RB active|active|JJ hyaluronan|hyaluronan|NN -|-|HYPH adhesive|adhesive|JJ CD44|cd44|NN by|by|IN activating|activate|VBG sialidase|sialidase|NN through|through|IN p38|p38|NN mitogen|mitogen|NN -|-|HYPH activated|activate|VBN protein|protein|NN kinase|kinase|NN in|in|IN lipopolysaccharide|lipopolysaccharide|NN -|-|HYPH stimulated|stimulate|VBN human|human|JJ monocytic|monocytic|JJ cells|cell|NNS .|.|. 
J|J|NNP Biol|Biol|NNP Chem|Chem|NNP .|.|. 
2003|2003|CD ;|;|: 278|278|CD (|(|-LRB- 39|39|CD )|)|-RRB- :|:|: 37275|37275|CD --|--|: 37287|37287|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12867430|12867430|CD ]|]|-RRB- 66|66|CD .|.|. 
Firan|Firan|NNP M|M|NNP ,|,|, Dhillon|Dhillon|NNP S|S|NNP ,|,|, Estess|Estess|NNP P|P|NNP ,|,|, Siegelman|Siegelman|NNP MH|MH|NNP .|.|. 
Suppressor|suppressor|NN activity|activity|NN and|and|CC potency|potency|NN among|among|IN regulatory|regulatory|JJ T|t|NN cells|cell|NNS is|be|VBZ discriminated|discriminate|VBN by|by|IN functionally|functionally|RB active|active|JJ CD44|cd44|NN .|.|. 
Blood|blood|NN .|.|. 
2006|2006|CD ;|;|: 107|107|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 619|619|CD --|--|: 627|627|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 16179372|16179372|CD ]|]|-RRB- 67|67|CD .|.|. 
Berg|Berg|NNP DJ|DJ|NNP ,|,|, Davidson|Davidson|NNP N|N|NNP ,|,|, Kuhn|Kuhn|NNP R|R|NNP ,|,|, Muller|Muller|NNP W|W|NNP ,|,|, Menon|Menon|NNP S|S|NNP ,|,|, Holland|Holland|NNP G|G|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Enterocolitis|Enterocolitis|NNP and|and|CC colon|colon|NN cancer|cancer|NN in|in|IN interleukin|interleukin|NN -10-deficient|-10-deficient|NN mice|mouse|NNS are|be|VBP associated|associate|VBN with|with|IN aberrant|aberrant|JJ cytokine|cytokine|NN production|production|NN and|and|CC CD4|cd4|NN (|(|-LRB- +|+|SYM )|)|-RRB- TH1|th1|NN -|-|HYPH like|like|JJ responses|response|NNS .|.|. 
J|J|NNP Clin|Clin|NNP Invest|Invest|NNP .|.|. 
1996|1996|CD ;|;|: 98|98|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 1010|1010|CD --|--|: 1020|1020|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 8770874|8770874|CD ]|]|-RRB- 68|68|CD .|.|. 
Sturlan|Sturlan|NNP S|S|NNP ,|,|, Oberhuber|Oberhuber|NNP G|G|NNP ,|,|, Beinhauer|Beinhauer|NNP BG|bg|NN ,|,|, Tichy|Tichy|NNP B|B|NNP ,|,|, Kappel|Kappel|NNP S|S|NNP ,|,|, Wang|Wang|NNP J|J|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Interleukin|interleukin|NN -10-deficient|-10-deficient|NN mice|mouse|NNS and|and|CC inflammatory|inflammatory|JJ bowel|bowel|NN disease|disease|NN associated|associate|VBN cancer|cancer|NN development|development|NN .|.|. 
Carcinogenesis|carcinogenesis|NN .|.|. 
2001|2001|CD ;|;|: 22|22|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 665|665|CD --|--|: 671|671|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 11285204|11285204|CD ]|]|-RRB- 69|69|CD .|.|. 
Ishida|Ishida|NNP D|D|NNP ,|,|, Yang|Yang|NNP H|H|NNP ,|,|, Masuda|Masuda|NNP K|K|NNP ,|,|, Uesugi|Uesugi|NNP K|K|NNP ,|,|, Kawamoto|Kawamoto|NNP H|H|NNP ,|,|, Hattori|Hattori|NNP M|M|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Antigen|Antigen|NNP -|-|HYPH driven|drive|VBN T|t|NN cell|cell|NN anergy|anergy|NN and|and|CC defective|defective|JJ memory|memory|NN T|t|NN cell|cell|NN response|response|NN via|via|IN deregulated|deregulate|VBN Rap1|rap1|NN activation|activation|NN in|in|IN SPA|SPA|NNP -1-deficient|-1-deficient|JJ mice|mouse|NNS .|.|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 2003|2003|CD ;|;|: 100|100|CD (|(|-LRB- 19|19|CD )|)|-RRB- :|:|: 10919|10919|CD --|--|: 10924|10924|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 12958214|12958214|CD ]|]|-RRB- 70|70|CD .|.|. 
Fadl|Fadl|NNP AA|AA|NNP ,|,|, Sha|Sha|NNP J|J|NNP ,|,|, Klimpel|Klimpel|NNP GR|GR|NNP ,|,|, Olano|Olano|NNP JP|JP|NNP ,|,|, Galindo|Galindo|NNP CL|CL|NNP ,|,|, Chopra|Chopra|NNP AK|AK|NNP .|.|. 
Attenuation|attenuation|NN of|of|IN Salmonella|Salmonella|NNP enterica|enterica|NNP Serovar|Serovar|NNP Typhimurium|Typhimurium|NNP by|by|IN altering|alter|VBG biological|biological|JJ functions|function|NNS of|of|IN murein|murein|NN lipoprotein|lipoprotein|NN and|and|CC lipopolysaccharide|lipopolysaccharide|NN .|.|. 
Infect|infect|VB Immun|Immun|NNP .|.|. 
2005|2005|CD ;|;|: 73|73|CD (|(|-LRB- 12|12|CD )|)|-RRB- :|:|: 8433|8433|CD --|--|: 8436|8436|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 16299345|16299345|CD ]|]|-RRB- 71|71|CD .|.|. 
al|al|NNP -|-|HYPH Ramadi|Ramadi|NNP BK|BK|NNP ,|,|, Fernandez|Fernandez|NNP -|-|HYPH Cabezudo|Cabezudo|NNP MJ|MJ|NNP ,|,|, El|El|NNP -|-|HYPH Hasasna|Hasasna|NNP H|h|NN ,|,|, Al|Al|NNP -|-|HYPH Salam|Salam|NNP S|S|NNP ,|,|, Bashir|Bashir|NNP G|G|NNP ,|,|, Chouaib|Chouaib|NNP S.|S.|NNP Potent|Potent|NNP anti-tumor|anti-tumor|JJ activity|activity|NN of|of|IN systemically|systemically|RB -|-|HYPH administered|administer|VBN IL2|il2|NN -|-|HYPH expressing|express|VBG Salmonella|salmonella|NN correlates|correlate|VBZ with|with|IN decreased|decrease|VBN angiogenesis|angiogenesis|NN and|and|CC enhanced|enhance|VBN tumor|tumor|NN apoptosis|apoptosis|NN .|.|. 
Clin|Clin|NNP Immunol|Immunol|NNP .|.|. 
2009|2009|CD ;|;|: 130|130|CD (|(|-LRB- 1|1|CD )|)|-RRB- :|:|: 89|89|CD --|--|: 97|97|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 18849195|18849195|CD ]|]|-RRB- 72|72|CD .|.|. 
Sha|Sha|NNP J|J|NNP ,|,|, Fadl|Fadl|NNP AA|AA|NNP ,|,|, Klimpel|Klimpel|NNP GR|GR|NNP ,|,|, Niesel|Niesel|NNP DW|DW|NNP ,|,|, Popov|Popov|NNP VL|VL|NNP ,|,|, Chopra|Chopra|NNP AK|AK|NNP .|.|. 
The|the|DT two|two|CD murein|murein|NN lipoproteins|lipoprotein|NNS of|of|IN Salmonella|Salmonella|NNP enterica|enterica|NNP serovar|serovar|NNP Typhimurium|Typhimurium|NNP contribute|contribute|VBP to|to|IN the|the|DT virulence|virulence|NN of|of|IN the|the|DT organism|organism|NN .|.|. 
Infect|infect|VB Immun|Immun|NNP .|.|. 
2004|2004|CD ;|;|: 72|72|CD (|(|-LRB- 7|7|CD )|)|-RRB- :|:|: 3987|3987|CD --|--|: 4003|4003|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 15213144|15213144|CD ]|]|-RRB- 73|73|CD .|.|. 
Fadl|Fadl|NNP AA|AA|NNP ,|,|, Sha|Sha|NNP J|J|NNP ,|,|, Klimpel|Klimpel|NNP GR|GR|NNP ,|,|, Olano|Olano|NNP JP|JP|NNP ,|,|, Niesel|Niesel|NNP DW|DW|NNP ,|,|, Chopra|Chopra|NNP AK|AK|NNP .|.|. 
Murein|Murein|NNP lipoprotein|lipoprotein|NN is|be|VBZ a|a|DT critical|critical|JJ outer|outer|JJ membrane|membrane|NN component|component|NN involved|involve|VBN in|in|IN Salmonella|salmonella|NN enterica|enterica|NN serovar|serovar|NN typhimurium|typhimurium|NN systemic|systemic|JJ infection|infection|NN .|.|. 
Infect|infect|VB Immun|Immun|NNP .|.|. 
2005|2005|CD ;|;|: 73|73|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 1081|1081|CD --|--|: 1096|1096|CD .|.|. 
[|[|-LRB- PubMed|PubMed|NNP :|:|: 15664952|15664952|CD ]|]|-RRB- Figure|figure|NN 1|1|CD .|.|. 
Suppression|suppression|NN of|of|IN tumor|tumor|NN growth|growth|NN in|in|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS by|by|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS A.|A.|NNP C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 5|5|CD /|/|SYM group|group|NN )|)|-RRB- were|be|VBD infected|infect|VBN via|via|IN the|the|DT i.p.|i.p.|RB route|route|NN with|with|IN 50|50|CD cfu|cfu|NN /|/|SYM 100|100|CD µl|µl|NN of|of|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS ,|,|, with|with|IN mice|mouse|NNS receiving|receive|VBG PBS|pbs|NN as|as|IN a|a|DT control|control|NN .|.|. 
After|after|IN 30|30|CD days|day|NNS ,|,|, B16|b16|NN melanoma|melanoma|NN cells|cell|NNS (|(|-LRB- 5|5|CD ×|×|SYM 105/100|105/100|CD µl|µl|NN )|)|-RRB- were|be|VBD subcutaneously|subcutaneously|RB injected|inject|VBN into|into|IN mice|mouse|NNS and|and|CC the|the|DT latter|latter|JJ observed|observe|VBN over|over|IN a|a|DT period|period|NN of|of|IN 24|24|CD days|day|NNS .|.|. 
B.|B.|NNP Mice|mouse|NNS were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN or|or|CC the|the|DT lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
After|after|IN 30|30|CD days|day|NNS ,|,|, these|these|DT mice|mouse|NNS were|be|VBD re-challenged|re-challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
Two|two|CD weeks|week|NNS later|later|RB ,|,|, B16|b16|NN cells|cell|NNS were|be|VBD subcutaneously|subcutaneously|RB injected|inject|VBN into|into|IN mice|mouse|NNS and|and|CC the|the|DT sizes|size|NNS of|of|IN tumors|tumor|NNS monitored|monitor|VBN over|over|IN a|a|DT period|period|NN of|of|IN 24|24|CD days|day|NNS .|.|. 
The|the|DT mean|mean|JJ tumor|tumor|NN size|size|NN ±|±|SYM standard|standard|JJ deviation|deviation|NN is|be|VBZ presented|present|VBN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Statistically|statistically|RB significant|significant|JJ data|datum|NNS are|be|VBP indicated|indicate|VBN by|by|IN asterisks|asterisk|NNS (|(|-LRB- *|*|NFP p|p|NN <|<|SYM 0.05|0.05|CD ,|,|, **|**|NFP p|p|NN <|<|SYM 0.01|0.01|CD ,|,|, and|and|CC ***|***|NFP p|p|NN <|<|SYM 0.001|0.001|CD )|)|-RRB- .|.|. 
Figure|figure|NN 2|2|CD .|.|. 
WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN down|down|RB -|-|HYPH regulated|regulate|VBN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS in|in|IN mice|mouse|NNS .|.|. 
A.|A.|NNP Swiss|Swiss|NNP -|-|HYPH Webster|Webster|NNP Mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 3|3|CD /|/|SYM group|group|NN )|)|-RRB- were|be|VBD infected|infect|VBN with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppAB|lppab|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN (|(|-LRB- 1|1|CD ×|×|SYM 103|103|CD cfu|cfu|NN /|/|SYM mouse|mouse|NN )|)|-RRB- .|.|. 
After|after|IN 5|5|CD days|day|NNS ,|,|, the|the|DT spleens|spleen|NNS from|from|IN infected|infected|JJ mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD4|anti-cd4|JJ FITC|fitc|NN and|and|CC anti-CD25|anti-cd25|JJ PE|pe|NN antibodies|antibody|NNS and|and|CC splenocytes|splenocyte|NNS analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
B.|B.|NNP Mice|mouse|NNS splenocytes|splenocyte|NNS were|be|VBD cultured|culture|VBN with|with|IN either|either|CC WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC LPS|lps|NN (|(|-LRB- 3|3|CD µg|µg|NN /|/|SYM ml|ml|NN )|)|-RRB- .|.|. 
After|after|IN 24|24|CD h|h|NN ,|,|, the|the|DT cells|cell|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD4|anti-cd4|JJ FITC|fitc|NN and|and|CC Foxp3|foxp3|NN PE|pe|NN -|-|HYPH Cy5|cy5|NN antibodies|antibody|NNS and|and|CC splenocytes|splenocyte|NNS analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Figure|figure|NN 3|3|CD .|.|. 
Infection|infection|NN of|of|IN immunized|immunize|VBN mice|mouse|NNS with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP increased|increase|VBD the|the|DT number|number|NN of|of|IN CD4|cd4|NN ,|,|, CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM ,|,|, NK|NK|NNP cells|cell|NNS as|as|RB well|well|RB as|as|IN macrophages|macrophage|NNS in|in|IN tumors|tumor|NNS of|of|IN mice|mouse|NNS .|.|. 
Mice|mouse|NNS were|be|VBD immunized|immunize|VBN with|with|IN the|the|DT lppAB|lppab|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
After|after|IN 30|30|CD days|day|NNS ,|,|, these|these|DT mice|mouse|NNS were|be|VBD challenged|challenge|VBN with|with|IN the|the|DT WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC the|the|DT lpp|lpp|NN mutant|mutant|NN at|at|IN a|a|DT dose|dose|NN of|of|IN 2|2|CD ×|×|SYM 103|103|CD cfu|cfu|NN .|.|. 
Two|two|CD weeks|week|NNS later|later|RB ,|,|, B16|b16|NN cells|cell|NNS were|be|VBD subcutaneously|subcutaneously|RB injected|inject|VBN into|into|IN mice|mouse|NNS ,|,|, and|and|CC then|then|RB three|three|CD weeks|week|NNS later|later|RB ,|,|, tumor|tumor|NN cells|cell|NNS were|be|VBD removed|remove|VBN and|and|CC stained|stain|VBN with|with|IN CD4|cd4|NN -|-|HYPH PE|pe|NN -|-|HYPH Cy7|cy7|NN ,|,|, CD25|cd25|NN -|-|HYPH APC|apc|NN ,|,|, NK1.1|nk1.1|NN -|-|HYPH FITC|fitc|NN ,|,|, CD11b|cd11b|NN -|-|HYPH PE|pe|NN ,|,|, CD3|cd3|NN -|-|HYPH PE|pe|NN ,|,|, and|and|CC IFNγ|ifnγ|NN --|--|: FITC|fitc|NN antibody|antibody|NN for|for|IN analysis|analysis|NN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Statistically|statistically|RB significant|significant|JJ data|datum|NNS are|be|VBP indicated|indicate|VBN by|by|IN asterisks|asterisk|NNS (|(|-LRB- **|**|NFP p|p|NN <|<|SYM 0.01|0.01|CD ,|,|, ***|***|NFP p|p|NN <|<|SYM 0.001|0.001|CD )|)|-RRB- .|.|. 
WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP and|and|CC its|its|PRP$ lpp|lpp|NN /|/|HYPH msbB|msbb|NN mutant|mutant|NN strains|strain|NNS down|down|IN -|-|HYPH regulated|regulate|VBN expression|expression|NN of|of|IN CD44|cd44|NN in|in|IN B16|b16|NN tumor|tumor|NN cells|cell|NNS and|and|CC in|in|IN the|the|DT splenocytes|splenocyte|NNS of|of|IN mice|mouse|NNS .|.|. 
A.|A.|NNP B16|b16|NN cells|cell|NNS were|be|VBD infected|infect|VBN with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppB|lppb|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS .|.|. 
After|after|IN 24|24|CD h|h|NN ,|,|, the|the|DT cells|cell|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN .|.|. 
B.|B.|NNP Swiss|Swiss|NNP -|-|HYPH Webster|Webster|NNP mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 3|3|CD /|/|SYM group|group|NN )|)|-RRB- were|be|VBD treated|treat|VBN with|with|IN WT|wt|NN S.|S.|NNP Typhimurium|Typhimurium|NNP or|or|CC its|its|PRP$ lppB|lppb|NN /|/|HYPH msbB|msbb|NN and|and|CC lppB|lppb|NN /|/|HYPH msbB|msbb|NN mutants|mutant|NNS ,|,|, with|with|IN uninfected|uninfected|JJ mice|mouse|NNS as|as|IN negative|negative|JJ controls|control|NNS .|.|. 
After|after|IN 5|5|CD days|day|NNS ,|,|, the|the|DT splenocytes|splenocyte|NNS from|from|IN infected|infected|JJ and|and|CC uninfected|uninfected|JJ mice|mouse|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD4|anti-cd4|JJ PE|pe|NN antibody|antibody|NN and|and|CC the|the|DT data|datum|NNS analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
An|a|DT isotype|isotype|NN control|control|NN is|be|VBZ shown|show|VBN as|as|IN a|a|DT light|light|NN -|-|HYPH colored|color|VBN line|line|NN on|on|IN the|the|DT left|left|NN of|of|IN each|each|DT panel|panel|NN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Figure|figure|NN 4|4|CD .|.|. 
Figure|figure|NN 5|5|CD .|.|. 
The|the|DT population|population|NN of|of|IN CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM Treg|Treg|NNP cells|cell|NNS in|in|IN CD44high|cd44high|NN cells|cell|NNS from|from|IN spleens|spleen|NNS of|of|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD and|and|CC IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS .|.|. 
Splenocytes|splenocyte|NNS from|from|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD and|and|CC IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS (|(|-LRB- 3|3|CD =|=|SYM /|/|HYPH group|group|NN )|)|-RRB- were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN ,|,|, anti-CD4|anti-cd4|JJ FITC|fitc|NN and|and|CC anti-CD25|anti-cd25|JJ APC|apc|NN antibodies|antibody|NNS ,|,|, and|and|CC analyzed|analyze|VBN by|by|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
A.|A.|NNP CD44med|CD44med|NNP and|and|CC CD44high|cd44high|NN cells|cell|NNS were|be|VBD gated|gate|VBN .|.|. 
In|in|IN splenocytes|splenocyte|NNS ,|,|, R1|r1|NN =|=|SYM lymphocytes|lymphocyte|NNS ,|,|, R1|r1|NN +|+|SYM R2|r2|NN =|=|SYM CD44high|cd44high|NN cells|cell|NNS R1|r1|NN +|+|SYM R3|r3|NN =|=|SYM CD44med|cd44med|CD .|.|. 
B.|B.|NNP CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM CD44|cd44|NN cells|cell|NNS in|in|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD mice|mouse|NNS .|.|. 
C.|C.|NNP CD4|cd4|NN +|+|SYM CD25|cd25|NN +|+|SYM CD44|cd44|NN cells|cell|NNS in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS (|(|-LRB- 10|10|CD /|/|SYM group|group|NN )|)|-RRB- were|be|VBD subcutaneously|subcutaneously|RB injected|inject|VBN with|with|IN B16|b16|NN tumor|tumor|NN cells|cell|NNS .|.|. 
After|after|IN 24|24|CD days|day|NNS ,|,|, the|the|DT mice|mouse|NNS with|with|IN bigger|bigger|JJR or|or|CC smaller|smaller|JJR tumors|tumor|NNS were|be|VBD sacrificed|sacrifice|VBN ,|,|, and|and|CC the|the|DT splenocytes|splenocyte|NNS were|be|VBD stained|stain|VBN with|with|IN mouse|mouse|NN anti-CD44|anti-cd44|JJ PE|pe|NN antibodies|antibody|NNS .|.|. 
These|these|DT stained|stain|VBN cells|cell|NNS were|be|VBD then|then|RB analyzed|analyze|VBN with|with|IN flow|flow|NN cytometry|cytometry|NN .|.|. 
A.|A.|NNP CD44|cd44|NN expression|expression|NN in|in|IN the|the|DT spleens|spleen|NNS of|of|IN C57BL|c57bl|NN /|/|HYPH 6|6|CD young|young|JJ and|and|CC aged|aged|JJ mice|mouse|NNS .|.|. 
B.|B.|NNP CD44|cd44|NN expression|expression|NN in|in|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM young|young|JJ and|and|CC aged|aged|JJ mice|mouse|NNS .|.|. 
C.|C.|NNP CD44|CD44|NNP expression|expression|NN in|in|IN the|the|DT smaller|smaller|JJR and|and|CC larger|larger|JJR tumors|tumor|NNS of|of|IN IL|il|NN -|-|HYPH 10|10|CD −|−|SYM /|/|HYPH −|−|SYM aged|aged|JJ mice|mouse|NNS .|.|. 
An|a|DT isotype|isotype|NN control|control|NN is|be|VBZ shown|show|VBN as|as|IN a|a|DT light|light|NN -|-|HYPH colored|color|VBN line|line|NN on|on|IN the|the|DT left|left|NN of|of|IN each|each|DT panel|panel|NN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Figure|figure|NN 6|6|CD .|.|. 
Figure|figure|NN 7|7|CD .|.|. 
Growth|growth|NN of|of|IN human|human|JJ CD44|cd44|NN liver|liver|NN cancer|cancer|NN cells|cell|NNS in|in|IN mice|mouse|NNS .|.|. 
Both|both|DT CD44|cd44|NN +|+|SYM and|and|CC CD44|cd44|NN −|−|SYM cells|cell|NNS from|from|IN human|human|JJ liver|liver|NN cancer|cancer|NN were|be|VBD sorted|sort|VBN and|and|CC subcutaneously|subcutaneously|RB injected|inject|VBN into|into|IN BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 5|5|CD /|/|SYM group|group|NN )|)|-RRB- .|.|. 
The|the|DT tumor|tumor|NN size|size|NN was|be|VBD measured|measure|VBN over|over|IN a|a|DT period|period|NN of|of|IN 20|20|CD days|day|NNS .|.|. 
The|the|DT mean|mean|JJ tumor|tumor|NN size|size|NN ±|±|SYM standard|standard|JJ deviation|deviation|NN is|be|VBZ presented|present|VBN .|.|. 
These|these|DT profiles|profile|NNS are|be|VBP representative|representative|JJ results|result|NNS from|from|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
Statistically|statistically|RB significant|significant|JJ data|datum|NNS are|be|VBP indicated|indicate|VBN by|by|IN asterisks|asterisk|NNS (|(|-LRB- ***|***|NFP p|p|NN <|<|SYM 0.001|0.001|CD )|)|-RRB- .|.|. 
References|reference|NNS 
